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Abstract		
The	 interrelationship	 between	 microtubules	 and	 the	 actin	 cytoskeleton	 in	mechanoregulation	of	 integrin-mediated	adhesions	 is	poorly	understood.	Here,	we	show	that	the	effects	of	microtubules	on	two	major	types	of	cell-matrix	adhesions,	focal	adhesions	and	podosomes,	are	mediated	by	KANK	family	proteins	connecting	the	adhesion	protein	talin	with	microtubule	tips.	Both	total	microtubule	disruption	and	microtubule	uncoupling	from	adhesions	by	manipulations	with	KANKs	trigger	a	massive	 assembly	 of	 myosin-IIA	 filaments,	 augmenting	 focal	 adhesions	 and	disrupting	 podosomes.	 Myosin-IIA	 filaments	 are	 indispensable	 effectors	 in	 the	microtubule-driven	regulation	of	integrin-mediated	adhesions.	Myosin-IIA	filament	assembly	depends	on	Rho	activation	by	 the	RhoGEF,	GEF-H1,	which	 is	 trapped	by	microtubules	when	they	are	connected	with	integrin-mediated	adhesions	via	KANK	proteins	 but	 released	 after	 their	 disconnection.	 Thus,	 microtubule	 capturing	 by	integrin-mediated	 adhesions	 modulates	 the	 GEF-H1-dependent	 effect	 of	microtubules	 on	 the	 assembly	 of	 myosin-IIA	 filaments.	 Subsequent	 actomyosin	reorganization	 then	 remodels	 the	 focal	 adhesions	 and	 podosomes,	 closing	 the	regulatory	loop.	
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Main		The	 cytoskeleton	 is	 a	 composite	 material	 comprised	 of	 several	 types	 of	 fibrillar	structures	and	molecular	motors	1.	 	The	coordinated	function	of	these	cytoskeletal	elements	 is	 poorly	 understood.	 We	 focus	 here	 on	 the	 crosstalk	 between	microtubules	and	the	specialized	domains	of	the	actin	cytoskeleton,	focal	adhesions	and	podosomes.			Focal	 adhesions	 are	 elongated	 micron-sized	 clusters	 of	 transmembrane	 integrin	molecules	associated	with	a	complex	network	of	plaque	proteins	that	connect	them	to	 bundles	 of	 actin	 filaments2-4.	 It	 was	 shown	 long	 ago	 that	 disruption	 of	microtubules	by	microtubule-depolymerizing	agents	leads	to	a	substantial	increase	in	 the	 size	 and	 in	 some	 cases	 the	 number	 of	 mature	 focal	 adhesions	 5,6,	 whilst	microtubule	 outgrowth	 following	 washout	 of	 microtubule-depolymerizing	 drugs	leads	to	a	transient	decrease	in	size	or	even	the	disappearance	of	focal	adhesions	7.	Different	 facets	 of	 these	 phenomena	 have	 been	 investigated	 and	 several	mechanisms	 were	 suggested	 (See	 Supplementary	 Information).	 Recent	 studies	revealed	 that	 novel	 components	 of	 focal	 adhesions,	 KANK1	 and	 KANK2,	 can	physically	 connect	 focal	 adhesions	 and	 microtubule	 tips.	 Indeed,	 KANKs	 interact	with	 a	major	 integrin-associated	 protein,	 talin,	 	 and,	 via	a	 and	b	 liprins,	with	 the	cortical	microtubule	 docking	 complex	 (liprins,	 ELKS,	 LL5b),	which	 in	 turn	bind	 to	CLASP	end-tracking	proteins8-12.	In	addition,	KANK	proteins	can	bind	directly	to	the	microtubule	plus-end	motor	KIF21A	8,11	and,	at	least	in	Drosophila,	to	EB1	13.		Podosomes	 are	 another	 integrin-based	 cell-matrix	 adhesions	 common	 in	 cells	 of	monocytic	origin	but	found	also	in	cells	of	several	other	types14,15.	The	characteristic	structural	 feature	 of	 a	 podosome	 is	 a	 submembranous	 actin	 core	 formed	 due	 to	Arp2/3-dependent	 actin	 polymerization.	 The	 actin	 core	 is	 associated	 with	 an	approximately	 ring-shaped	 cluster	 of	 adhesion	 proteins	 including	 transmembrane	integrin	molecules	 and	 the	 plaque	molecules	 (paxillin,	 talin,	 vinculin	 etc.)	 linking	
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integrins	to	the	actin	network,	essentially	similar	to	those	in	focal	adhesions.	Unlike	focal	 adhesions,	 podosomes	 integrity	 does	 not	 require	 actomyosin-dependent	traction	forces	16.	Importantly,	in	contrast	to	the	case	for	focal	adhesions,	disruption	of	 microtubules	 in	 macrophage-like	 cells	 results	 in	 a	 rapid	 disassembly	 of	podosomes	 17,18.	 Several	mechanisms	 involved	 in	 this	 process	 has	 been	 proposed	(see	Supplementary	Information).			The	contrast	between	the	effects	of	microtubule	disruption	on	focal	adhesions	and	podosomes	led	to	a	suggestion	that	microtubules	regulate	these	integrin	adhesions	using	 different	 mechanisms.	 In	 this	 study	 we	 surprisingly	 find	 a	 common	mechanism	 underlying	 the	 effect	 of	 microtubules	 on	 both	 focal	 adhesions	 and	podosomes.	We	present	evidence	that	the	common	mechanism	operates	via	KANK	family	proteins	and	 the	GEF-H1-dependent	 local	 regulation	of	myosin-IIA	 filament	assembly	by	microtubules.			 	
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Phenocopying	microtubule	disruption	by	hindering	KANK’s	function		We	 addressed	 the	 effect	 of	 perturbations	 of	 the	 microtubule	 network	 on	 focal	adhesions	 and	 podosomes.	 Human	 fibrosarcoma	 cell	 line,	 HT1080	 display	 a	well-developed	 system	 of	 focal	 adhesions,	 while	 the	 human	monocytic	 THP1	 cell	 line,	which	 upon	 treatment	 with	 transforming	 growth	 factor-beta	 1	 (TGFb1)	 undergo	differentiation	 into	macrophage-like	 cells,	 form	numerous	podosomes	 19.	We	used	THP1	cells	treated	with	TGFb1	in	all	the	experiments	presented	in	this	paper.			Treatment	 with	 1	 µM	 nocodazole	 disrupted	 microtubules	 completely	 in	 both	HT1080	 and	 THP1	 cells	 (Figure	 1).	 To	 uncouple	 microtubules	 from	 adhesion	structures	 in	 a	 more	 physiological	 manner,	 we	 experimentally	 perturbed	 KANK1	and	 KANK2	 proteins	 connecting	 microtubule	 tips	 with	 integrin	 adhesions	 8,10	(Figure	 1).	 We	 then	 compared	 the	 effects	 of	 total	 microtubule	 disruption	 on	podosomes	and	focal	adhesions	with	those	caused	by	depletion	of	KANK1	or	KANK2	(Figure	 1	 and	 Supplementary	 Figure	 1).	 In	 agreement	 with	 previous	 studies,	 we	found	that	disruption	of	microtubules	 led	to	an	 increase	of	 focal	adhesion	number	and	size	in	HT1080	cells	(Figure	1A,	B	and	R),	but	completely	disrupted	podosomes	in	TGFb1-stimulated	THP1	cells	(Figure	1G,	H,	S	and	T).			As	shown	by	gene	expression	profiling	(Supplementary	Table	1),	both	KANK1	and	KANK2	isoforms	are	expressed	in	HT1080	and	THP1	cells.	Expression	of	two	other	isoforms,	KANK3	and	KANK4	was	negligible.	We	confirmed	previous	observations	on	the	localization	of	GFP-KANK1	and	2	around	focal	adhesion	plaques	8,9	(Figure	1L	and	 M).	 We	 further	 demonstrated	 that	 in	 THP1	 cells,	 GFP-KANK1	 localize	 to	 the	external	 ring	 surrounding	 podosomes	 (Panel	 O	 in	 Figure	 1	 and	 Supplementary	Figure	1A).	Similar	localization	of	KANK1	around	podosomes	was	also	observed	in	phorbol	12-myristate	13-acetate	(PMA)-stimulated	murine	macrophage	RAW	264.7	macrophages	(Supplementary	Figure	2A).	Association	of	KANK2	with	podosomes	in	
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THP1	cell	was	 less	prominent	than	that	of	KANK1,	even	though	a	small	number	of	podosomes	were	surrounded	by	KANK2-positive	rings	(Figure	1P).									In	HT1080	 cells,	 knockdown	 of	 either	 KANK1	 or	 KANK2	 produced	 an	 increase	 in	focal	adhesion	size	similar	to	total	disruption	of	microtubules	by	nocodazole	(Figure	1A-F	and	R).	The	double	knockdown	of	KANK1	and	KANK2	affected	focal	adhesions	more	 strongly	 than	 the	 knockdown	 of	 KANK1	 or	 KANK2	 alone	 (Figure	 1R	 ,	Supplementary	 Figure	 1C).	 In	 THP1	 cells,	 knockdown	 of	 KANK1	 and	 KANK2	produced	 different	 effects	 (Figure	 1G-K).	 Only	 the	 knockdown	 of	 KANK1	 induced	pronounced	disruption	of	podosomes	in	THP1	cells,	phenocopying	the	effect	of	total	microtubule	disruption.	Knockdown	of	KANK2	did	not	significantly	affect	podosome	number	 in	 THP1	 cells	 (Figure	 1K,	 S	 and	 T)	 even	 though	 it	 increased	 the	 cell	projection	area	(Supplementary	Figure	1B).			In	 addition	 to	 KANK1/2	 knockdown,	 we	 uncoupled	 microtubules	 from	 integrin	adhesions	by	overexpression	of	KANK1/2	truncated	constructs,	GFP-KANK1-KN	and	GFP-KANK2-KN,	 which	 bind	 to	 talin	 but	 not	 to	 microtubules	 8,9	 (Figure	 1C).	 We	anticipated	that	these	constructs	would	compete	with	endogenous	KANK1	and	2	for	binding	to	talin.	 Indeed,	expression	of	either	GFP-KANK1-KN	or	GFP-KANK2-KN	in	HT1080	 cells	 resulted	 in	 localization	 of	 these	 constructs	 to	 focal	 adhesions	 and	elimination	 of	 endogenous	 KANK2	 from	 this	 location	 (Figure	 1N,	 Supplementary	Figures	1D	and	E).	Then	we	examined	how	such	treatment	affected	focal	adhesions.	Overexpression	 of	 GFP-KANK1-KN	 or	 GFP-KANK2-KN	 led	 to	 an	 increase	 in	 focal	adhesion	 size	 (Figure	1N,	R	 and	 Supplementary	Figure	1E),	 similarly	 to	KANK1/2	knockdowns.	An	increase	in	focal	adhesion	size	upon	overexpression	of	KN	domains	of	KANK1	or	KANK2	was	also	observed	in	human	colon	adenocarcinoma	line	(HT-29)	 cells	 and	 human	 umbilical	 vein	 endothelial	 cells	 (HUVECs)	 (Supplementary	Figure	2E-K).							We	then	overexpressed	GFP-KANK1-KN	or	GFP-KANK2-KN	in	THP1	cells	and	found	that	excess	of	KN	domain	of	either	KANK1	or	KANK2	led	to	a	significant	reduction	in	
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podosome	number	and	the	appearance	of	focal	adhesion-like	structures,	resembling	the	effects	of	KANK1	knockdown	(Figure	1Q,	S,	T,	Supplementary	Figure	1F).	Both	exogenous	GFP-KANK1-KN	and	GFP-KANK2-KN	were	 localized	 to	 the	 few	residual	podosomes	and	 to	newly-formed	 focal	adhesion-like	structures.	This	suggests	 that	the	KN	domains	of	KANK1	and	KANK2	are	 similar	 and	 compete	with	 endogenous	KANK1	 for	 binding	 to	 talin	 in	 podosomes.	 Similar	 effects	 were	 also	 observed	 in	another	 podosome-forming	 cell	 type,	 RAW	 264.7	 macrophages,	 in	 which	overexpression	of	GFP-KANK1-KN	led	to	elimination	of	podosomes	and	formation	of	numerous	focal	adhesion-like	structures	(Supplementary	Figure	2B-D).					To	 understand	 why	 KANK2,	 unlike	 KANK1,	 is	 poorly	 localized	 to	 podosomes,	 in	spite	of	 the	 functional	similarity	of	 their	KN	domains,	we	examined	the	role	of	 the	liprin-binding	coiled-coil	domains	of	KANK1	and	KANK2	8,9.	We	created	a	chimeric	construct	of	KANK2	(KANK2/CC-KANK1)	 in	which	 its	own	coiled-coil	domain	was	substituted	with	that	of	KANK1	(Supplementary	Figure	3A).	Such	chimeric	construct	localized	 to	 podosome	 rings	much	 better	 than	 KANK2	 (Supplementary	 Figure	 3B	and	 C).	 Moreover,	 while	 wild-type	 KANK2	 did	 not	 rescue	 podosomes	 in	 KANK1-depleted	 cells,	 the	 GFP	 fusion	 of	 KANK2/CC-KANK1	 induced	 formation	 of	podosomes	 in	 cells	 lacking	 KANK1	 (Supplementary	 Figure	 3D,	 E	 and	 F).	 This	suggests	 that	 the	 differential	 role	 of	 KANK1	 and	 KANK2	 in	 podosome	 regulation	depends	on	differences	in	their	liprin-binding	domains.			We	 further	 performed	 additional	 rescue	 experiments	 on	 KANK1-depleted	 THP1	cells	 and	KANK2-depleted	HT1080	cells	using	various	deletion	mutants	of	KANK1	and	 KANK2,	 respectively	 (Supplementary	 Figure	 4A	 and	 F).	 The	 constructs	 (GFP-KANK1∆ANKR,	GFP-KANK2	(1-670))	 containing	 the	 talin-binding	domain	 together	with	the	coil-coiled	liprin-binding	domain	rescued	the	effects	of	KANK1	and	KANK2	knockdowns	 respectively,	 similarly	 to	 the	 full-length	 KANK1	 or	 KANK2	(Supplementary	 Figure	 4B,	 C,	 G,	 H,	 K-M).	 Of	 note	 here,	 the	 C-terminal	 regions	 of	KANK1	 and	 KANK2	 containing	 ankyrin	 repeats	 known	 to	 be	 involved	 in	 binding	KIF21A	kinesin	11,	appeared	to	be	dispensable	for	the	KANK1	effect	on	podosomes	
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and	KANK2	effect	on	focal	adhesions.		At	the	same	time,	the	constructs	consisting	of	talin-binding	domain	alone	(GFP-KANK1-KN,	GFP-KANK2-KN),	or	constructs	lacking	a	 talin-binding	 domain	 (GFP-KANK1-CC-Cter,	 GFP-KANK2∆KN),	which	 cannot	 link	talin-containing	structures	with	microtubules,	did	not	rescue	 the	effects	of	KANK1	knockdown	 on	 podosomes	 and	 KANK2	 knockdown	 on	 focal	 adhesions	(Supplementary	Figure	4D,	E,	I,	J,	K-M).			
	
KANKs	control	focal	adhesion	by	linking	them	to	microtubules	To	study	the	role	of	KANK	proteins	in	microtubule	targeting	to	focal	adhesions,	we	plated	 HT1080	 cells	 onto	 patterned	 substrata	 consisting	 of	 4	 µm	 diameter	fibronectin	 islands	 (Figure	 2A).	 Cells	 spreading	 on	 such	 substrata	 form	 focal	adhesions	 only	within	 these	 islands	 (Figure	 2B).	 In	 control	 cells,	microtubule	 tips	are	 concentrated	 at	 such	 islands	 but	 not	 at	 circular	 areas	 of	 similar	 dimension	lacking	 focal	 adhesions	 (Figure	 2C,	 E,	 F	 and	 Supplementary	 Movie	 1).	 In	 cells	depleted	 of	 KANK1	 and	 KANK2,	 the	 microtubule	 tips	 were	 randomly	 distributed	(Figure	2D,	E	and	G,	Supplementary	Movie	2).								While	 disruption	 of	 microtubules	 resulted	 in	 augmentation	 of	 focal	 adhesions,	microtubule	 outgrowth	 after	 nocodazole	 washout	 led	 to	 transient	 disassembly	 of	focal	 adhesions	 (7,20	 and	 Supplementary	Movie	 3).	 To	 elucidate	 the	 role	 of	 KANK-mediated	microtubule	 targeting	 in	 the	 negative	 regulation	 of	 focal	 adhesions,	 we	used	the	technique	of	rapamycin-induced	dimerization	to	link	two	parts	of	KANK1	protein:	the	KN	talin-binding	domain	and	the	remaining	part	of	the	molecule	(DKN)	(Figure	 2H).	 Transfection	 of	 HT1080	 cells	 with	 mApple-KN-FRB	 and	 FKBP-DKN-mEmerald	resulted	in	localization	of	mApple-KN-FRB	(green)	to	focal	adhesions	and	diffuse	 distribution	 of	 FKBP-DKN-mEmerald	 (red)(Figure	 2I).	 The	 addition	 of	rapamycin,	 which	 links	 mApple-KN-FRB	 with	 FKBP-DKN-mEmerald,	 led	 to	accumulation	 of	 FKBP-DKN-mEmerald	 to	 KN-containing	 adhesions	 and	subsequently	 triggered	 transient	 disassembly	 of	 focal	 adhesion	 as	 manifested	 by	disappearance	 of	 vinculin	 (Figure	 2I	 and	 I’,	 Supplementary	Movie	 4).	 Coupling	 of	
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microtubules	 to	 focal	 adhesions	 by	 rapamycin-induced	 dimerization	 of	 KANK1	domains,	also	resulted	in	a	rapid	decrease	of	traction	forces	exerted	by	cell	(Figure	2J),	which,	in	view	of	focal	adhesion	mechanosensitivity,	could	be	the	cause	of	focal	adhesion	disassembly.				
Myosin-II	filaments	mediate	microtubule	effects	on	adhesions	We	 found	 that	 disruption	 of	 microtubules	 or	 uncoupling	 them	 from	 integrin	adhesions	 resulted	 in	massive	 formation	of	 new	myosin-II	 filaments	 visualized	by	SIM	 using	 myosin-II	 regulatory	 light	 chain	 or	 myosin-IIA	 heavy	 chain	 labeling	(Figure	3).	This	effect	was	especially	dramatic	in	THP1	cells,	which	normally	contain	only	 a	 peripheral	 rim	of	myosin-II	 filaments	 associated	with	 circumferential	 actin	bundles.	 (Figure	 3A,	 Supplementary	 Movie	 5).	 Upon	 addition	 of	 nocodazole,	disassembly	 of	 podosomes	 followed	 a	 drastic	 increase	 in	 the	 number	 of	 new	myosin-II	filaments	(Figure	3A,	A’,	J,	K,	Supplementary	Movie	5).	The	newly-formed	myosin-II	 filaments	 aligned	 in	 registry	 forming	 “stacks”	 21	 (Figure	 3A,	 E	 and	Supplementary	Movie	 5).	 Simultaneously,	 short	 actin	 filament	 bundles	 associated	with	 newly	 formed	 focal	 adhesion-like	 structures	 appeared	 (Figure	 3E	 and	 L).	 In	HT1080	cells,	the	disruption	of	microtubules	also	significantly	increased	the	amount	of	 myosin-II	 filaments	 located	 in	 the	 central	 part	 of	 the	 cell.	 This	 increase	 was	accompanied	by	growth	of	focal	adhesions	(Figure	3B,	B’,	Supplementary	Movie	6).	The	 epithelial	 HT-29	 cells	 also	 responded	 to	 microtubule	 disruption	 by	augmentation	 of	 myosin-II	 filaments	 (Supplementary	 Figure	 2E,	 F)	 in	 agreement	with	22.		Knockdown	 of	 KANK1	 in	 THP1	 cells	 also	 produced	 a	 significant	 increase	 of	 the	number	of	myosin-IIA	filaments	organized	into	stacks,	as	well	as	formation	of	focal	adhesion-like	 structures	 (Figure	 3G	 and	 L).	 In	 HT1080	 cells,	 KANK2	 knockdown	resulted	 in	 significant	 increase	 in	 formation	 of	 myosin-II	 filaments	 and	 focal	adhesion	area	(Supplementary	Figure	5A	and	C).				
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To	 ascertain	 whether	 myosin-IIA	 filament	 assembly	 and	 disassembly	 are	consequential	or	causal	factors	that	account	for	the	changes	in	focal	adhesions	and	podosomes,	 we	 interfered	 with	 myosin-II	 filament	 formation	 by	 siRNA-mediated	knockdown	 of	 myosin-IIA.	 In	 THP1	 cells	 lacking	 myosin-IIA,	 podosomes	 were	insensitive	to	disruption	of	microtubules	by	nocodazole	or	their	disconnection	from	integrin	adhesions	by	depletion	of	KANK1	(Figure	3C-K).	Consistent	with	previous	studies	 23,24,	 we	 found	 that	 myosin	 IIA-depleted	 HT1080	 cells	 essentially	 lack	mature	 focal	 adhesions	but	 contain	 small	 nascent	 adhesions	 at	 the	 cell	 periphery.	The	size	of	these	adhesions	did	not	increase	upon	either	treatment	with	nocodazole	or	 by	 KANK2	 knockdown	 (Supplementary	 Figure	 5A-C).	 Thus,	 we	 conclude	 that	depletion	of	myosin-IIA	filaments	abolished	the	effect	of	microtubule	disruption,	or	disconnection	from	integrin-mediated	adhesions	by	KANK1/2	knockdown,	on	both	focal	adhesions	and	podosomes.			Unlike	 myosin-IIA,	 the	 knockdown	 of	 myosin-IIB	 did	 not	 prevent	 the	 effects	 of	microtubule	 disruption	 or	 disconnection	 from	 integrin	 adhesions	 on	 both	 focal	adhesions	and	podosomes	(Supplementary	Figure	5D-K).			Recovery	 of	microtubules	 following	 nocodazole	washout	 in	HT1080	 cells	 led	 to	 a	rapid	decrease	in	myosin-II	filament	number	and	the	traction	forces	exerted	by	cells	on	 a	 substrate,	 which	 returned	 to	 the	 control	 level	 20	 minutes	 following	 the	washout	(Supplementary	Figure	6A-D,	Supplementary	Movie	7	and	Supplementary	Movie	8).	The	drop	in	traction	forces	preceded	the	decrease	in	focal	adhesion	size,	while	 the	 recovery	of	 traction	 forces	preceded	 the	enlargement	of	 focal	adhesions	(Supplementary	 Figure	 6D)	 consistent	 with	 the	 concept	 of	 focal	 adhesion	mechanosensitivity25.				Finally,	 we	 found	 that	 effect	 of	 microtubule	 recovery	 on	 myosin-II	 filaments	 and	focal	 adhesions	 is	 reduced	 in	 HT1080	 cells	 lacking	 KANK2.	 KANK2-depleted	HT1080	 cells	did	not	demonstrate	 a	pronounced	drop	 in	 the	 amount	of	myosin-II	filaments	 and	 focal	 adhesion	 area	 under	 condition	 of	 microtubule	 outgrowth	
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(Supplementary	 Figure	 6E-G,	 Supplementary	 Movie	 9).	 Together	 with	 data	 on	decrease	 of	 traction	 force	 and	 focal	 adhesions	 upon	 chemically-induced	dimerization	 of	 KANK	 domains	 (Figure	 2H-J),	 these	 data	 suggest	 that	 the	microtubule	 effect	 on	 myosin-II	 filaments	 and	 focal	 adhesions	 depends	 on	 local	interactions	of	microtubules	with	focal	adhesions	via	KANK	proteins.				
	
Microtubules	control	integrin	adhesions	via	Rho-ROCK	axis	
	Microtubule	 disruption	 as	well	 as	KANK1	depletion	 resulted	 in	 an	 increase	 in	 the	fraction	of	RhoA-GTP	in	both	HT1080	and	THP1	cells	(Supplementary	Figure	7A	and	B)	in	agreement	with	previous	studies	26,27.	KANK2	knockdown	also	led	to	increased	RhoA-GTP	 levels	 in	HT1080	 cells	 but	 not	 in	 THP1	 cells	 Supplementary	 Figure	 7A	and	B)	 consistent	with	 the	 lack	of	 the	 effect	KANK2	knockdown	on	podosomes	 in	these	cells	(Figure	1K,	S	and	T).					We	 further	 found	 that	 Rho	 activation	 by	 the	 small	 peptide	 CN03,	 mimicked	 the	disruptive	 effect	 of	 microtubule	 disassembly	 or	 KANK1	 depletion	 on	 podosomes	(Supplementary	Figure	7C,	C’,	 Supplementary	Movie	10).	 Inhibition	of	ROCK	by	Y-27632	or	thiazovivin,	did	not	affect	podosomes	in	control	THP1	cells,	but	prevented	the	 podosome	 disruption	 after	 nocodazole	 treatment	 (Figure	 4C	 and	 D,	Supplementary	Figure	7D,	E,	G-K,	 Supplementary	Movie	11,	 Supplementary	Movie	12	 and	 Supplementary	 Movie	 13).	 Moreover,	 addition	 of	 Y-27632	 to	 THP1	 cells	incubated	 with	 nocodazole	 and	 demonstrating	 enhanced	 level	 of	 myosin-II	filaments	 along	with	 complete	 lack	 of	 podosomes,	 rapidly	disassembled	myosin-II	filaments	 and	 subsequently	 rescued	podosomes	 (Figure	4C	 and	D,	 Supplementary	Figure	7F	and	F’,	Supplementary	Movie	14).			Inhibition	 of	 ROCK	 by	 Y-27632	 also	 led	 to	 rescue	 of	 podosomes	 in	 KANK1	knockdown	 THP1	 cells	 (Figure	 4A-D,	 Supplementary	 Movie	 15).	 Rescued	podosomes	were	functionally	active	in	terms	of	their	ability	to	degrade	extracellular	matrix.	The	podosomes	of	control	THP1	cell	actively	degrade	fluorescent	gelatin	in	
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agreement	with	previous	studies	28.	The	depletion	of	KANK1	induced	elimination	of	podosomes	 and	 formation	 of	 focal	 adhesions,	which	 also	 degraded	 gelatin	 (c.f.	 29)	but	far	weaker	than	podosomes.	Treatment	of	KANK1-depleted	cells	with	Y-27632	not	only	rescued	morphologically	normal	podosomes	but	also	restored	 the	gelatin	degradation	pattern	(Figure	4E).						Data	 showing	 podosome	 rescue	 in	 KANK1	 knockdown	 cells	 by	 treatment	with	 Y-27632	make	it	possible	to	check	that	KANK1	is	 indeed	responsible	for	targeting	of	microtubules	 to	 podosomes.	 We	 plated	 podosome-forming	 THP1	 cells	 on	 micro-patterned	substrata	so	that	podosomes	were	formed	only	inside	the	small	adhesive	islands.	In	THP1	cells	transfected	with	control	siRNA,	microtubule	tips	overlap	with	podosomes	at	 adhesive	 islands	 at	 the	 lowest	 focal	plane	 (z=	0	µm)	 (Figure	4I).	 In	cells	lacking	KANK1,	podosomes	were	absent	and	microtubule	tips	were	not	found	at	 the	z=0	µm	plane,	where	 focal	adhesion-like	structure	were	 located	(Figure	4J).		Treatment	 with	 Y-27632	 by	 itself	 affected	 neither	 podosome	 formation	 nor	localization	of	microtubules	to	podosome-containing	islands	(Figure	4K).	In	KANK1	knockdown	cells	treated	with	Y-27632,	the	recovered	podosomes,	unlike	the	control	ones,	 were	 not	 colocalized	 with	 microtubule	 tips	 at	 z=0	 µm	 plane	 (Figure	 4L).	Quantification	 of	 the	 association	 of	 microtubule	 tips	 with	 podosomes	 at	 micro-patterned	 adhesive	 islands	 is	 given	 in	 Figure	 7C-D.	 These	 data	 (quantified	 in	Supplementary	Figure	8)	 showed	 that	KANK1	 is	 indeed	necessary	 for	 targeting	of	microtubules	 to	 podosomes.	 In	 addition,	 these	 results	 show	 that	 functional	podosomes	can	be	maintained	without	a	connection	to	microtubules	if	Rho/ROCK-dependent	myosin-II	filament	formation	is	suppressed.					Whilst	 disruption	 of	 podosomes	 is	 induced	 by	 disruption	 of	 microtubules,	disruption	of	focal	adhesion	occurs	upon	microtubule	outgrowth.	We	showed	above	that	this	process	was	preceded	by	the	decrease	of	traction	forces	due	to	disassembly	of	 myosin-II	 filaments	 (Supplementary	 Figure	 6A-D).	 Expression	 of	 either	constitutively	 active	RhoA	 (Q63L),	 or	 constitutively	 active	ROCK	mutant	 (rat	Rok-
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alpha	 1-543aa)	 known	 to	 activate	 myosin-II	 filament	 formation	 prevented	 the	disruptive	 effect	 of	 microtubule	 outgrowth	 on	 focal	 adhesions	 in	 HT1080	 cells	(Supplementary	 Figure	 7L-N,	 Supplementary	 Movie	 16).	 Thus,	 we	 conclude	 that	microtubules	regulate	focal	adhesions	through	the	same	pathway	as	podosomes,	via	modulation	of	Rho/ROCK	activity.				
Microtubule	capturing	by	adhesions	control	GEF-H1	function		The	Rho	nucleotide	exchange	factor,	GEF-H1	is	associated	with	microtubules	in	both	THP1	and	HT1080	cells	as	well	as	HUVECs,	and	demonstrated	diffuse	distribution	upon	microtubule	disruption	(Figure	5A	and	B,	Supplementary	Figure	9A,	B	and	F),	in	 agreement	with	 previous	 observations	 30-32.	 Remarkably,	 diffuse	 localization	 of	GEF-H1	was	also	observed	upon	knockdown	of	KANK1	in	THP1	cells	and	HUVECs,	or	KANK1	and	KANK2	in	HT1080	cells,	even	though	microtubule	integrity	was	well	preserved	(Figure	5A-C,	Supplementary	Figure	9A-G).	Moreover,	overexpression	of	KANK1-KN	 talin-binding	 domain	 reproduced	 the	 effect	 of	 KANK1	 knockdown	 on	GEF-H1	 localization	 in	 THP1	 cells	 (Figure	 5D).	 Thus,	 not	 only	 the	 disruption	 of	microtubules	 but	merely	 the	 uncoupling	 of	microtubules	 from	 integrin	 adhesions	led	to	release	of	GEF-H1.			Next,	 we	 investigated	 whether	 GEF-H1	 depletion	 prevents	 the	 effects	 of	 KANK	knockdowns	on	 the	myosin-II	 filaments	 and	 integrin	 adhesions	 in	 both	THP1	 and	HT1080	cells.			GEF-H1	knockdown	THP1	cells	essentially	preserved	the	phenotype	of	control	cells,	having	myosin-II	filaments	at	the	periphery	and	podosomes	in	the	central	area.	The	integrity	 of	 the	 microtubule	 network	 was	 also	 unchanged	 (Figure	 5F	 and	 G,	Supplementary	Figure	9H	and	I).	Disruption	of	microtubules	in	GEF-H1	knockdown	cells	however	did	not	result	in	augmentation	of	myosin-II	filaments	and	did	not	lead	to	 podosome	 disassembly	 and	 formation	 of	 focal	 adhesion-like	 structures.	Moreover,	double	knockdown	of	GEF-H1	and	KANK1	also	did	not	lead	to	a	reduction	
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in	 podosome	 number,	 unlike	 the	 knockdown	 of	 KANK1	 alone.	 Finally,	 GEF-H1	knockdown	 also	 prevented	 the	 effect	 of	 overexpression	 of	 KANK1	 talin-binding	domain,	GFP-KANK1-KN	(Figure	5H-P,	Supplementary	Figure	9J-M).			In	HT1080	 cells	 lacking	GEF-H1,	 the	 disruption	 of	microtubules	 by	 nocodazole	 as	well	 as	disconnection	of	microtubules	 from	adhesions	by	KANK2	knockdown	only	weakly,	if	at	all,	increased	focal	adhesion	size	above	its	level	in	cells	with	knockdown	of	 GEF-H1	 alone.	 Similarly,	 knockdown	 of	 GEF-H1	 reduced	 the	 increase	 of	 focal	adhesion	 size	 in	 cells	 overexpressing	 the	 GFP-KANK2-KN	 (Supplementary	 Figure	10A-H	and	K,	 graph	 in	 Supplementary	Figure	11).	Whilst	 in	 control	HT1080	 cells,	microtubule	outgrowth	produced	transient	disassembly	of	focal	adhesions,	in	GEF-H1-depleted	 HT1080	 cells,	 focal	 adhesion	 disruption	 upon	 microtubule	 recovery	was	 less	 pronounced	 (Supplementary	 Figure	 10I-K,	 Supplementary	 Movie	 17).	Altogether,	 these	 results	 show	 that	 both	 the	 protective	 effect	 of	 microtubules	 on	podosomes	 and	 suppressive	 effect	 on	 focal	 adhesions	 are	 mediated	 via	 GEF-H1	regulation.								Of	note	in	this	study,	possible	off-target	effects	of	Dharmacon	SMARTpool	siRNAs	against	myosin-IIA	and	GEF-H1	were	excluded	by	validation	experiments	using	individual	siRNAs	taken	from	the	corresponding	SMARTpools	(Supplementary	Figure	11).			 	
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In	 this	 study,	 we	 have	 discovered	 a	 mechanism	 for	 the	 microtubule-mediated	regulation	 of	 both	 focal	 adhesions	 and	 podosomes	 operating	 via	 KANK	 family	proteins	 and	 GEF-H1-dependent	 reorganization	 of	myosin-II	 filaments	 (Figure	 6).	KANKs	 are	 required	 for	 targeting	 of	 microtubules	 to	 both	 types	 of	 integrin	adhesions	 by	 linking	 talin	 to	 the	 liprin-containing	 cortical	 microtubule	 docking	complex	(8,10	and	this	study).	Both	depletion	of	KANKs	and	their	displacement	from	talin	by	overexpression	of	 talin-binding	KN	domain	of	KANKs	 faithfully	 reproduce	the	 contrasting	 effects	 of	 total	 microtubule	 disruption:	 elimination	 of	 podosomes	and	augmentation	of	 focal	adhesions	 in	several	 cell	 types.	This	 indicates	 that	both	supportive	 effect	 of	 microtubules	 on	 podosomes	 and	 suppressive	 effect	 on	 focal	adhesions	 are	 mediated	 by	 KANKs.	 Indeed,	 linking	 the	 microtubules	 and	 focal	adhesions	 by	 rapamycin-induced	 dimerization	 of	 KN	 domain	 with	 the	 remaining	part	of	KANK,	leads	to	disassembly	of	focal	adhesions.	The	coiled-coil	liprin-binding	domain	of	KANK	proteins,	 together	with	KN	domain	were	necessary	and	sufficient	to	restore	the	effect	of	microtubules	on	integrin	adhesions	in	KANK-depleted	cells.	KANK1	and	KANK2	isoforms	are	not	entirely	equivalent.	While	 the	KN	domains	of	KANK1	and	KANK2	were	shown	to	be	 functionally	similar,	 the	coiled-coil	domains	are	 different,	 which	 explains	 the	 differential	 effects	 of	 KANK1	 and	 KANK2	knockdowns	on	podosomes.					Studying	 the	 effects	 of	 microtubule	 disruption	 or	 uncoupling	 from	 integrin	adhesions	 using	 SIM	microscopy,	 we	 demonstrate	 that	 the	major	 consequence	 of	such	 treatments	 is	 a	 dramatic	 increase	 in	 the	 number	 of	 myosin-II	 filaments.	Moreover,	a	burst	of	microtubule	polymerization	resulted	in	a	transient	decrease	in	the	number	of	myosin-II	filaments.	The	magnitude	of	traction	forces	exerted	by	cells	essentially	 follows	the	quantity	of	myosin-II	 filaments,	which	explains	 the	changes	in	traction	force	upon	KANK2	knockdown	and	its	rescue	observed	in	9.			We	 demonstrated	 that	 the	 effects	 of	 microtubule	 disruption	 or	 uncoupling	 from	talin	 on	 podosomes	 and	 focal	 adhesions	 can	 be	 efficiently	 abolished	 by	 various	pharmacological	and	genetic	manipulations	affecting	myosin-IIA	filament	assembly.	
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In	 particular,	 disassembly	 of	 myosin-II	 filament	 by	 ROCK	 inhibition	 recovered	functionally	 active	 podosomes	 in	 spite	 of	 their	 uncoupling	 from	 microtubules	 or	even	 total	 microtubule	 disruption.	 These	 experiments	 show	 that	 KANK-mediated	links	between	integrin	adhesions	and	microtubules	controls	the	integrin	adhesions	indirectly	 via	 regulation	 of	 the	 assembly	 of	 myosin-II	 filaments,	 which	 then	remodels	these	adhesions.			How	does	microtubule	disruption	or	their	uncoupling	from	adhesions	affect	myosin-II	filament	assembly?	We	investigated	the	role	of	the	RhoGEF,	GEF-H1	known	to	be	associated	with	microtubules	30,31,33	in	this	process.	We	have	shown	that	knockdown	of	 GEF-H1	 renders	 the	 level	 of	myosin-II	 filament	 polymerization	 independent	 of	microtubule	 integrity	 or	 their	 association	 with	 adhesion	 structures.	 In	 GEF-H1	knockdown	 cells,	 neither	 microtubule	 disruption	 nor	 KANK	 depletion,	 nor	 its	displacement	from	talin	led	to	podosome	disassembly	or	focal	adhesion	growth.		It	is	 suggested	 that	 GEF-H1	 undergoes	 inactivation	 when	 associated	 with	microtubules	 and	 is	 rapidly	 activated	 upon	 microtubule	 disruption	 30,34.	 Our	experiments	 showed	 that	 GEF-H1	 can	 be	 released	 from	 microtubules	 and	apparently	 activated	 not	 only	 upon	 microtubule	 disruption	 but	 also	 upon	uncoupling	 microtubules	 from	 integrin	 adhesions	 by	 KANK	 knockdown	 or	displacement	 from	 talin.	 Previous	 studies	 have	 already	 demonstrated	 that	knockdown	of	KANK1	27	and	KANK2	35	led	to	activation	of	Rho	but	overlooked	the	role	of	GEF-H1	in	such	activation.	Our	experiments	suggest	that	it	is	not	merely	the	presence	 of	 KANK	 in	 the	 cytoplasm	 but	 its	 simultaneous	 binding	 to	 talin	 and	microtubules	 that	 is	 required	 for	 suppression	 of	 Rho	 activity,	 most	 probably	 by	arresting	GEF-H1	on	microtubules	(Figure	6).		It	 remains	 to	 be	 studied	 which	 changes	 in	 biochemistry	 or	 mechanics	 of	microtubules	 induced	by	their	uncoupling	from	integrin	adhesions	are	responsible	for	 release	 and	 activation	 of	 GEF-H1.	 It	 is	 possible	 that	 disconnection	 of	microtubules	from	adhesions	intensifies	their	dynamics	and	consequently	the	GEF-H1	turnover.	Coupling/uncoupling	of	microtubules	from	integrin	adhesions	can	also	
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alter	the	organization	of	microtubule	lattice	affecting	the	release	of	GEF-H1	from	the	microtubule	 wall.	 Indeed,	 recent	 studies	 demonstrated	 that	 microtubule	 bending	can	modify	the	lattice	triggering	tubulin	acetylation	36,37.			Proteins	associated	with	microtubules	 can	participate	 in	 the	 regulation	of	GEF-H1	release.	Of	note,	knockdown	of	EB1,	a	plus-end	tracking	protein	possibly	involved	in	microtubule	 connection	 to	 integrin	 adhesions,	 was	 shown	 to	 promote	 release	 of	GEF-H1	 from	 microtubules	 38.	 	 In	 addition,	 depletion	 of	 vimentin	 intermediate	filaments	was	 shown	 to	 result	 in	 GEF-H1-dependent	 Rho	 activation	 32,	 suggesting	yet	another	avenue	for	such	regulation.			The	question	of	why	myosin-IIA	filaments	affect	podosomes	and	focal	adhesions	in	such	 a	 different	 and	 contrasting	 manner	 remains	 open.	 Myosin-IIA	 filaments	promote	 assembly	 of	 mechanosensitive	 focal	 adhesions	 by	 generation	 of	 traction	forces	 25,39	 and	 stabilizing	 the	 focal	 adhesion-associated	 stress	 fibers	 40-42.	 The	sensitivity	of	the	actin	core	of	podosomes	to	mechanical	factors	differs	from	that	of	focal	adhesion	plaques.	Podosomes	can	form	in	the	absence	of	traction	forces	in	cells	plated	 on	 a	 fluid	 lipid	 bilayer	 16	 and	 in	 the	 presence	 of	 inhibitors	 of	 myosin-II	filament	formation	(43	and	this	study).	The	excess	of	myosin-II	filaments	may	induce	collapse	 of	 the	Arp2/3	branched	 actin	 networks	 at	 the	 podosome	 cores	 and	 their	rapid	 transformation	 into	 actomyosin	 bundle-like	 structures.	 Submembranous	myosin-II	 filaments	 may	 also	 reduce	 membrane	 curvature	 44	 and	 therefore	antagonize	podosome	integrity.			Microtubules	 control	 the	 directional	 migration	 of	 fibroblasts	 45	 regulating	 focal	adhesion	 turnover	 46.	 Podosomes	 are	 required	 for	migration	of	 some	 cell	 types	 47	and	their	integrity	depends	on	microtubules17.	Our	study	shows	that	both	turnover	of	 focal	 adhesions	 and	 maintenance	 of	 podosomes	 are	 controlled	 by	 linking	 of	microtubules	 to	 these	 adhesions	 via	 KANK	 proteins.	 Such	 linking	 regulates	 the	Rho/ROCK	signaling	axis	and	hence	the	myosin-IIA	filament	assembly	in	a	GEF-H1	dependent	 manner.	 It	 is	 reasonable	 to	 suggest	 that	 such	 regulation	 can	 operate	
17
	 18	
locally.	 Indeed,	 the	 formation	 of	 focal	 adhesions	 on	 rigid	 substrates	 creates	 a	positive	feedback	loop	involving	activation	of	Rho,	enhancement	of	myosin-II	driven	contractility	 and	 further	 growth	 of	 mechanosensitive	 focal	 adhesions48.	 To	 break	this	self-activating	loop	and	control	tension	homeostasis	49,	microtubule-dependent	mechanism	of	 local	 inhibition	of	Rho	activation	upon	 touching	 the	 focal	adhesions	seems	 plausible.	 At	 the	 trailing	 edge,	 the	 same	 mechanism	 could	 trigger	 the	disassembly	of	focal	adhesions	and	then	promote	the	burst	of	myosin-II	contractility	upon	 detachment	 of	 microtubules	 from	 these	 adhesions,	 which	 results	 in	 tail	retraction	 9,50,51.	 In	 podosome-forming	 cells,	 microtubule-driven	 suppression	 of	myosin-II	 activity	 can	 promote	 formation	 of	 podosomes	 at	 the	 leading	 edge,	permitting	directional	cell	movement	47.			
Conclusions		We	 demonstrated	 that	 interactions	 between	 two	 major	 elements	 of	 the	cytoskeleton,	microtubules	 and	 the	 actomyosin	 network,	 is	mediated	 by	 integrin-based	adhesions,	which	at	the	same	time	are	strongly	affected	by	these	interactions.	Linking	 microtubules	 with	 the	 cytoplasmic	 domains	 of	 integrin	 locally	 regulate	Rho/ROCK	signaling	that	affects	the	 formation	of	myosin-IIA	filaments.	Myosin-IIA	filaments	 in	 turn	 operate	 as	 effectors	 controlling	 integrin-based	 adhesions.	 This	feedback	 regulatory	 loop	 consisting	 of	 an	 interwoven	 mix	 of	 signaling	 and	mechanical	events	provides	a	basis	 for	understanding	 the	entire	cytoskeleton	as	a	smart	composite	material.		 	
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Materials	and	Methods		
Cell	culture	and	cell	transfection	procedures		THP1	 human	monocytic	 leukemia	 cell	 line	 was	 obtained	 from	 Health	 Protection	Agency	Culture	Collections	 (Porton	Down,	Salisbury,	UK)	and	cultured	 in	Roswell	Park	 Memorial	 Institute	 media	 (RPMI-1640)	 supplemented	 with	 10%	 heat-inactivated	FBS	and	50	µg/ml	2-Mercaptoethanol	(Sigma-Aldrich)	at	37°C	and	5%	CO2.	The	suspended	THP-1	cells	were	differentiated	into	adherent	macrophage-like	cells	with	1	ng/ml	human	recombinant	cytokine	TGFb1	(R&D	Systems)	for	24	or	48	hours	on	 fibronectin-coated	glass	substrates.	No	apparent	difference	between	 the	phenotype	of	 cells	 stimulated	 for	 24	or	 48	hours	were	detected.	 For	 the	 imaging	samples,	 35-mm	 ibidi	 (Cat.	 81158)	 glass-bottomed	 dishes	 were	 coated	 with	 1	
µg/ml	 of	 fibronectin	 (Calbiochem,	Merck	Millipore)	 in	 phosphate	 buffered	 saline	(PBS)	 for	 1-2	 hours	 at	 37°C,	washed	with	 PBS	 twice,	 and	 immersed	 in	 complete	medium	 prior	 to	 seeding	 of	 cells.	 RAW	 264.7	 murine	 macrophage	 cell	 line	 was	purchased	 from	 American	 Type	 Culture	 Collection	 (Manassas,	 VA,	 USA)	 and	cultured	 in	 the	 same	media	 used	 for	 THP1	 cells.	 For	 imaging,	 cells	were	 scraped	from	the	culture	dishes,	re-plated	at	the	appropriate	cell	density	and	differentiated	by	addition	of	100	ng/ml	phorbol	12-myristate	13-acetate	(PMA,	Sigma-Aldrich)	on	glass	bottom	dishes	for	at	least	24	hours.				HT1080	human	 fibrosarcoma	cell	 line	was	obtained	 from	American	Type	Culture	Collection	(Manassas,	VA,	USA)	and	cultured	in	MEM	supplemented	with	10%	heat-inactivated	FBS,	Non-essential	amino	acid	and	Sodium	Pyruvate	(Sigma-Aldrich),	in	an	incubator	at	37°C	and	5%	CO2.	HT-29	human	colon	adenocarcinoma	cell	line	was	gifted	from	Dr.	Sudhakar	Jha	(Cancer	Science	Institute,	Singapore)	and	cultured	in	DMEM	 supplemented	with	 10%	heat-inactivated	 FBS	 and	 penicillin-streptomycin	(Thermo	Fisher	Scientific),	 in	an	 incubator	at	37°C	and	5%	CO2.	 	Primary	human	umbilical	 vein	 endothelial	 cells	 (HUVECs)	 was	 a	 gift	 from	 Dr.	 Roger	 Kamm	(Singapore-MIT	 Alliance	 for	 Research	 and	 Technology,	 Singapore),	 which	 was	originally	purchased	from	American	Type	Culture	Collection	(Manassas,	VA,	USA).	
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HUVECs	were	cultured	using	EGM-2	BulletKit	media	(catalogue	no.	CC-3162,	Lonza,	MA).	 All	 cells	 were	 plated	 on	 fibronectin-coated	 surfaces	 for	 24	 hours	 prior	 to	imaging,	or	48	hours	for	knockdown	experiments.			Cells	were	transiently	transfected	prior	to	stimulation	with	the	expression	vectors	plasmids	 using	 electroporation	 (Neon	 Transfection	 System,	 Life	 Technologies)	 in	accordance	to	manufacturer’s	 instructions.	Specifically,	 two	pulses	of	1400V	of	20	ms	duration	were	used	 for	THP1	 cells,	 one	pulse	 of	 950V	of	 50	ms	was	used	 for	HT1080	cells,	two	pulses	of	1300V	of	20	ms	duration	for	HT-29	cells,	one	pulse	of	1200V	of	40	ms	duration	for	HUVECs	and	one	pulses	of	1680V	of	20	ms	duration	for	 RAW	 264.7	 macrophages.	 For	 siRNA-mediated	 knockdown,	 THP1	 cells	 were	transfected	at	the	following	concentrations:	150nM	for	KANK1	siRNA	(Dharmacon,	ON-TARGETplus	SMARTpool	siRNA,	catalogue	no.	L-012879-01-0005),	100nM	for	KANK2	 siRNA	 (Dharmacon,	 ON-TARGETplus	 SMARTpool	 siRNA,	 catalogue	 no.	 L-027345-00-0005),	 150nM	 for	 MYH9	 siRNA	 (Dharmacon,	 ON-TARGETplus	SMARTpool	 siRNA	 catalogue	 no.	 L-007668-00-0005),	 150nM	 for	 MYH9	 siRNA	(Dharmacon,	ON-TARGETplus	siRNA	catalogue	no.	LQ-007668-00-0002,	containing	following	 individual	 siRNA;	 J-007668-05	 (#05),	 J-007668-06	 (#06),	 J-007668-07	(#07)	 and	 J-007668-08	 (#08)),	 150nM	 for	 MYH10	 siRNA	 (Dharmacon,	 ON-TARGETplus	SMARTpool	siRNA	catalogue	no.	L-023017-00-0005),	150nM	for	GEF-H1	 siRNA	 (Dharmacon,	 ON-TARGETplus	 SMARTpool	 siRNA,	 catalogue	 no.	 L-009883-00-0005),	 and	 150nM	 for	 GEF-H1	 individual	 siRNA	 (GEF-H1	#09	 siRNA)	(Dharmacon,	ON-TARGETplus	siRNA,	catalogue	no.	J-009883-09-0002).	For	control	experiments,	 cells	 were	 transfected	 with	 non-targeting	 pool	 siRNA	 (Dharmacon,	ON-TARGETplus,	 catalogue	 no.	 D-001810-10)	 at	 a	 concentration	 similar	 to	 gene-targeted	 siRNAs.	 For	 siRNA-mediated	 knockdown	 in	 HUVECs,	 cells	 were	transfected	at	the	following	concentration:	100nM	for	KANK1	siRNA	(Dharmacon,	ON-TARGETplus	 SMARTpool	 siRNA,	 catalogue	 no.	 L-012879-01-0005).	 HT1080	cells	were	transfected	at	the	following	concentrations:	25nM	for	KANK1,	25nM	for	KANK2	 siRNA,	 50nM	 for	MYH9	 siRNA	 and	50nM	 for	GEF-H1	 siRNA	 (Dharmacon,	
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see	above)	using	DharmaFECT	1	transfection	reagent	(Dharmacon,	catalogue	no.	T-2001)	following	the	manufacturer’s	protocols.		
Plasmids	Expression	 vectors	 for	 fluorescent	 protein	 fusion	 constructs	 are	 described	 in	Supplementary	Information.		For	 generation	 of	 EGFP-KANK2/CC-KANK1	 chimeric	 construct,	 the	 liprin-binding	coiled-coil	 domain	 corresponding	 to	 amino	 acid	 residues	 188-238	 of	 full-length	KANK2	9	was	substituted	with	amino	acid	residues	of	257-500	of	full-length	KANK1	8.	 The	 EGFP-KANK2/CC-KANK1	 construct	 was	 cloned	 by	 Epoch	 Life	 Science	 Inc	(USA).	For	generation	of	constructs	used	in	the	rapamycin-induced	dimerization	of	KN	and	DKN	of	KANK1	protein,	KN	domain	of	KANK1	corresponding	to	amino	acid	residues	 1-68	 8	was	 fused	with	mApple	 fluorescence	 tag	 and	 FKBP12-rapamycin	binding	 (FRB)	 domain	 of	 mammalian	 target	 of	 rapamycin	 (mTOR)	 (mApple-KN-FRB).	 The	 rest	 of	 KANK1,	DKN,	 corresponding	 to	 amino	 acid	 residues	 69-1352	 8,	was	 fused	with	mEmerald	 fluorescence	 tag	 and	FK506	binding	protein	 (FKBP12)	rapamycin-binding	 domain	 (FKBP-DKN-mEmerald).	 The	 mApple-KN-FRB	 and	FKBP-DKN-mEmerald	constructs	were	cloned	by	Epoch	Life	Science	Inc	(USA).	
	
Live	cell	observations	Pharmacological	treatments	were	performed	using	the	following	concentrations	of	inhibitors	or	activators:	1	µM	for	Nocodazole	(Sigma-Aldrich),	30-100	µM	for	Y-27632	dihydrochloride	(Sigma-Aldrich),	8	µM	for	Thiazovivin	(Sigma-Aldrich),	and	1	µg/ml	for	Rho	Activator	II	(CN03,	Cytoskeleton),	1	µg/ml	rapamycin	(CAS	number	53123-88-9,	Santa	Cruz).	For	THP1	cells,	duration	of	the	treatment	with	the	inhibitors	was	1	hour.	In	some	cases,	cells	were	pre-treated	with	one	inhibitor	for	30	min	and	then	another	inhibitor	was	added	for	additional	1	hour.	For	nocodazole-washout	experiments,	transfected	HT1080	cells	were	plated	on	
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collagen	I-	coated	coverslips	for	overnight.	One	hour	prior	to	imaging,	nocodazole	in	fresh	L-15	medium	(Leibovitz,	Sigma-Aldrich)	with	10%	FBS	was	added	to	the	cells.	The	coverslips	were	mounted	in	a	perfusion	chamber	(CM-B25-1,	Chamlide	CMB	chamber).	Nocodazole	was	washed-out	by	fresh	L-15	medium	with	FBS	just	prior	to	the	start	of	the	acquisition.	For	immunofluorescence	observations,	the	cells	were	fixed	30	minutes	following	nocodazole	washout.				
Immunoblotting	Cells	were	 lysed	 in	RIPA	buffer	48	hours	after	 transfection	and	extracted	proteins	were	 separated	 by	 SDS-PAGE	 in	 4-20%	 SDS-polyacrylamide	 gel	 (Thermo	 Fisher	Scientific)	 and	 transferred	 to	 PVDF	 membranes	 (Bio-Rad)	 at	 75V	 for	 2	 hours.	Subsequently,	the	PVDF	membranes	were	blocked	for	1	hour	with	5%	non-fat	milk	(Bio-Rad)	or	bovine	serum	albumin	(BSA,	Sigma-Aldrich),	then	incubated	overnight	at	4°C	with	appropriate	antibodies:	anti-KANK1	(Bethyl	Laboratories,	catalogue	no.	A301-882A,	 dilution	 1:1000);	 anti-KANK2	 (Sigma-Aldrich,	 catalogue	 no.	HPA015643,	 dilution	 1:1000);	 Anti-non	 muscle	 myosin-IIA	 (Sigma-Aldrich,	catalogue	 no.	 M8064,	 dilution	 1:1000);	 anti-GEF-H1	 (Cell	 Signaling	 Technology,	catalogue	 no.	 4145,	 dilution	 1:1000);	 anti-a-tubulin	 (Sigma-Aldrich,	 catalogue	 no.	T6199,	dilution	1:3000);	anti-GAPDH	(Santa	Cruz	Biotechnology,	Inc.,	catalogue	no.	sc-32233,	dilution	1:3000);	anti-RhoA	(Santa	Cruz	Biotechnology,	Inc.,	catalogue	no	sc-418,	 dilution	 1:1000);	 anti-non	 	 muscle	 myosin-IIB	 (Developmental	 Studies	Hybridoma	Bank,	CMII	23,	dilution	1:1000).		Subsequently,	 the	PVDF	membranes	were	washed	3	 times	 (10	minutes	 each)	 and	probed	 by	 incubation	 for	 1	 hour	 with	 the	 appropriate	 secondary	 antibodies	conjugated	 with	 horseradish	 peroxidase	 (Bio-Rad).	 The	 membranes	 were	 then	washed	 three	 times	 (15	 minutes	 at	 room	 temperature	 each),	 developed	 using	Pierce™	ECL	western	blotting	substratum	(Thermo	Fisher	Scientific)	and	imaged	by	a	ChemiDoc	imaging	system	(Bio-Rad).		
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Uncropped	images	of	the	western	blots	presented	in	Figure	1D,	Figure	1I,	Figure	3I,	Figure	 5E,	 Supplementary	 Figure	 5A,	 Supplementary	 Figure	 7A,	 Supplementary	Figure	10A	of	this	paper	are	shown	in	Supplementary	Figures	12	and	13.			
RhoA	activity	assay	THP1	and	HT1080	cells	were	lysed	in	RIPA	buffer	for	five	minutes	on	ice	as	described	in	52,	then	centrifuged	at	15,000g	for	five	minutes	at	4°C.	The	supernatant	was	incubated	with	Glutathione-agarose	beads	coated	with	GST-tagged	Rho-binding	domain	of	Rhotekin	(provided	by	Dr.	Boon	Chuan	Low	(National	University	of	Singapore)	at	4°C	for	30	minutes.	The	beads	were	washed	three	times	with	chilled	RIPA	buffer	before	being	boiled	in	Laemmli	buffer.	Pulled-down	RhoA	was	immunoblotted	using	respective	antibodies	as	described	above,	and	normalized	to	total	RhoA	in	the	whole	cell	lysates.				
Immunofluorescence	Microscopy	HT1080	cells	were	pre-fixed	for	3	min	at	37°C	using	0.3	%	Glutaraldehyde	and	0.2%	TritonX-100	 in	 PHEM	 buffer	 (60	mM	 PIPES,	 27	mM	HEPES,	 10	mM	 EGTA,	 8	mM	MgSO4	´	 7H2O,	 pH	 7.0),	 and	 then	 post-fixed	 for	 15	 min	 at	 37°C	 using	 4	 %	 PFA	(Sigma-Aldrich)	in	PHEM	buffer.	After	fixation,	free	aldehyde	groups	were	quenched	with	 5	 mg/ml	 Sodium	 borohydride	 (Sigma-Aldrich)	 for	 5	 min,	 and	 cells	 were	washed	3	times	for	5	min	in	PBS	and	blocked	for	30	min	in	blocking	solution	(2	%	Bovine	 Serum	Albumin	 in	 PBS,	 Sigma-Aldrich).	 THP1	 Cells	were	 fixed	 for	 15	min	with	 3.7%	 PFA	 in	 PBS,	 washed	 twice	 in	 PBS,	 permeabilized	 for	 10	minutes	 with	0.5%	triton	X-100	(Sigma-Aldrich)	in	PBS,	and	then	washed	twice	again	in	PBS.	For	microtubule	visualization,	cells	were	fixed	and	simultaneously	permeabilized	for	15	min	 at	 37°C	 in	 a	 mixture	 of	 3%	 PFA–PBS,	 0.25%	 Triton-X-100	 and	 0.2%	glutaraldehyde	 in	 PBS,	 and	 then	 washed	 twice	 with	 PBS	 for	 10	 min.	 Before	immunostaining,	 samples	were	quenched	 for	15	min	on	 ice	with	1	mg/ml	 sodium	borohydride	in	cytoskeleton	buffer	(10	mM	MES,	150	mM	NaCl,	5	mM	EGTA,	5	mM	MgCl2,	5	mM	glucose,	pH	6.1).	For	GEF-H1	visualization,	cells	were	fixed	with	100%	
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methanol	for	5	min	at	-20°C.	Fixed	cells	were	blocked	with	5%	BSA	or	5%	FBS	for	1	hour	at	room	temperature	or	overnight	at	4°C	prior	to	incubation	with	the	following	primary	 antibodies:	 anti-tubulin	 (Sigma-Aldrich,	 catalogue	 no.	 T6199,	 dilution	1:300);	 anti-paxillin	 (BD	 catalogue	 no.	 610569,	 dilution	 1:200);	 anti-vinculin	(Sigma-Aldrich,	 catalogue	 no.	 V9131,	 dilution	 1:400);	 anti-KANK2	 (Sigma-Aldrich,	catalogue	no.	HPA015643,	dilution	1:200);	anti-non	muscle	heavy	chain	of	myosin-IIA	 (Sigma-Aldrich,	 catalogue	 no.	 M8064,	 dilution	 1:800);	 anti-GEF-H1	 (Abcam,	catalogue	 no.	 ab155785,	 dilution	 1:100);	 anti-non	 	 muscle	 myosin-IIB	(Developmental	 Studies	Hybridoma	Bank,	 CMII	 23,	 dilution	 1:100).	 Samples	were	washed	with	PBS	three	times	and	incubated	with	Alexa	Fluor-conjugated	secondary	antibodies	(Thermo	Fisher	Scientific)	for	1	hour	at	room	temperature,	 followed	by	three	washes	in	PBS.			F-actin	was	visualized	by	Alexa	Fluor	488	Phalloidin	(Thermo	Fisher	 Scientific),	 Phalloidin-TRITC	 (Sigma-Aldrich)	 or	 Alexa	 Fluor	 647	 Phalloidin	(Thermo	Fisher	Scientific).			
Fluorescence	Microscopy	For	 structured	 illumination	 microscopy,	 two	 types	 of	 equipment	 were	 used:	 1)	spinning-disc	 confocal	 microscopy	 coupled	 with	 the	 Live	 super-resolution	 (SR)	module	 (Roper	 Scientific),	 	 Nikon	 Eclipse	 Ti-E	 inverted	 microscope	 with	 Perfect	Focus	System,	controlled	by	MetaMorph	software	(Molecular	device)	supplemented	with	a	100x	oil	1.45	NA	CFI	Plan	Apo	Lambda	oil	 immersion	objective	and	sCMOS	camera	 (Prime	95B,	Photometrics),	2)	Nikon	N-SIM	microscope,	based	on	a	Nikon	Ti-E	 inverted	 microscope	 with	 Perfect	 Focus	 System	 controlled	 by	 Nikon	 NIS-Elements	AR	software	supplemented	with	a	100x	oil	immersion	objective	(1.40	NA,	CFI	 Plan-ApochromatVC)	 and	 EMCCD	 camera	 (Andor	 Ixon	 DU-897).	 For	 Total	Internal	Reflection	Fluorescence	 (TIRF)	microscopy,	 samples	were	 imaged	using	a	Nikon	 Ti-E	 inverted	 microscope	 controlled	 by	 Nikon	 NIS-Elements	 AR	 software,	supplemented	 with	 a	 60x	 1.49	 NA,	 Apo	 TIRF	 oil	 immersion	 objective	 lens	 and	sCMOS	camera	(Orca	Flash	4.0,	Hamamatsu	Photonics).		
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Traction	Force	Microscopy		To	prepare	polyacrylamide	gel	substrates,	25	mm	round	coverslips	were	activated	by	 treatment	 with	 1.2%	 3-(Methacryloyloxy)propyltrimethoxysilane	 (Shin-Etsu	Silicon,	KBE-503)	in	100	%	methanol	for	1h	followed	by	extensive	100	%	methanol	washing.	Then,	freshly	mixed	solution	of	0.145%	bis/12%	acrylamide	with	100	nm	yellow-green	 fluorescent	 beads	 (FluoSpheres,	 0.1μm,	 Thermo	 Fisher	 Scientific,	Cat#	F8803)	was	placed	on	dried-	and	activated-	coverslips	to	give	an	adhered	gel	with	stiffness	of	16kPa.	Coverslips	with	attached	gel	substrate	were	washed	three	times	 with	 0.1M	 HEPES-NaOH	 buffer	 (pH	 7.5)	 and	 conjugated	 with	 collagen	 I	(Thermo	 Fisher	 Scientific,	 A1048301)	 using	 sulfo-SANPAH	 (Thermo	 Fisher	Scientific)	 to	 facilitate	 cell	 attachment.	 HT1080	 cells	 were	 plated	 on	 the	polyacrylamide	gel	2	hours	prior	to	the	experiment	and	images	of	focal	adhesions	by	 RFP-Zyxin	 and	 beads	 were	 acquired	 by	 spinning	 disk	 confocal	 microscope	equipped	 with	 a	 60X	 water	 immersion	 objective	 (NA1.2,	 UPlanApo,	 Nikon)	 as	described	above.	After	acquisition,	0.5	%	trypsin-EDTA	was	added	into	chamber	to	remove	all	cells	from	the	substrate,	and	then	images	of	beads	were	captured	again.	The	traction	stress	field	was	computed	as	described	previously	53.	For	the	traction	force	measurement	shown	in	Figure	5H,	a	modified	version	of	the	traction	force	set	was	used.	A	thin	layer	(approximately	7	μm)	of	soft	PDMS	(Dow	Corning,	 LOT#0008602722)	 was	 spin	 coated	 onto	 a	 glass	 coverslip.	 The	 pre-polymer	mix,	 CY	52-276A	 and	CY	52-276B	were	 used	 at	 a	 1:1	 ratio.	 Sylgard	184	crossslinker	was	used	to	tune	the	stiffness	of	the	gel	for	proper	force	measurement	of	 cells	 (~95kPa).	 The	 gel	mixture	was	 spin	 coated	 on	 cleaned	 coverslips	 at	 300	rpm	for	20	secs,	followed	by	800	rpm	for	10	secs	and	then	6000	rpm	for	1	minute.	The	 coverslip	with	 the	 gel	was	 then	 cured	 for	1	hour	 at	 80°C.	The	 surface	of	 the	cured	gel	was	then	silanized	with	(3-aminopropyl)	triethoxysilane	for	2	hours.	The	coverslips	 were	 then	 incubated	 with	 carboxylate-modified	 dark	 red	 (660/680)	beads	 (FluoSpheres,	 0.04μm,	 Thermo	 Fisher	 Scientific,	 LOT#1871942)	 at	 a	concentration	 of	 0.00025%	 in	 a	 solution	 of	 0.1M	 sodium	 bicarbonate	 for	 30	minutes.	The	coverslips	with	attached	beads	were	then	rinsed	and	incubated	with	
27
	 28	
10	 μg/mL	 of	 fibronectin	 solution	 (dissolved	 in	 bicarbonate	 buffer)	 at	 room	temperature	 for	 30	minutes.	 The	 online	 Image	 J	 plugin	 was	 used	 to	 extract	 and	compute	the	force	from	the	displacement	field	obtained	from	live	cell	imaging	(See	https://sites.google.com/site/qingzongtseng/tfm	for	plugin	software	details).		
Micro-patterning	of	adhesive	islands	using	UV-induced	molecular	adsorption	Adhesive	islands	with	a	diameter	of	4	µm	were	printed	in	square	lattices	with	a	period	of	8	µm.	Clean	glass	coverslips	were	sealed	with	NOA	73	liquid	adhesive	to	plastic-containing	dishes	by	UV	treatment	for	2	minutes,	and	were	then	treated	with	oxygen	plasma	for	5	minutes.	The	coverslips	were	coated	with	PLL-g-PEG	(PLL(20)-g[3.5]-PEG(5),	SuSoS	AG,	Dübendorf,	Switzerland)	at	100	μg/mL	in	PBS	for	at	least	8	hours	followed	by	multiple	washes	with	PBS.	For	micropattern	printing,	PRIMO	system	(Alveole,	France)	mounted	on	an	inverted	microscope	(Nikon	Eclipse	Ti-E,	Japan)	equipped	with	a	motorized	scanning	stage	(Physik	Instrumente,	Germany)	was	used	as	Digital	Micro-mirror	Device	(DMD)	to	create	a	UV	pattern	at	105	µm	above	the	focal	plane	of	the	microscope.	After	alignment	of	specimen	with	the	UV	pattern	by	using	the	Leonardo	software	(Alveole,	France),	a	solution	of	photoinitiator	(PLPP,	Alveole,	France)	was	incubated	on	the	dishes.	Depending	on	the	UV	exposure	and	time,	the	UV-activated	photoinitiator	molecules	locally	cleaved	the	PEG	chains,	which	permits	subsequent	local	deposition	of	proteins.	The	dishes	were	washed	with	PBS	multiple	times	prior	to	incubation	with	labeled	fibronectin	(Rhodamine	Fibronectin,	Cytoskeleton,	Inc.,	50	μg/ml)	or	unlabeled	fibronectin	mixed	with	Fibrinogen	Alexa	647	(ThermoFisher	Scientific,	50	μg/mL)	at	a	ratio	of	20:1	for	10	minutes.	After	several	washes	with	PBS,	HT1080	or	THP1	cells	were	plated	on	these	micropatterned	lattices	for	SIM	imaging.				
Matrix	degradation	assay	50%	 sulphuric-acid-washed	 coverslips	were	 coated	with	 50	µg/ml	 poly-D-Lysine	for	30	minutes	at	room	temperature,	and	then	fixed	with	0.5%	glutaraldehyde	for	
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15	 minutes.	 0.2%	 gelatin	 warmed	 at	 37°C	 was	 mixed	 with	 Oregon	 Green	 488	conjugated-pig	gelatin	at	6:1	ratio.	Coverslips	were	coated	with	gelatin	mix	for	10	minutes,	 washed	 with	 1xPBS	 and	 then	 quenched	 with	 5	 mg/ml	 sodium	borohydride	for	15	minutes	followed	by	numerous	washes.	For	matrix	degradation	assay,	 cells	 were	 seeded	 on	 the	 gelatin-coated	 coverslips	 for	 8	 hours,	 fixed	 and	stained	as	described	above	(See	“immunofluorescence	microscopy”).	Dark	spots	on	the	fluorescently-labeled	gelatin	correspond	to	areas	of	matrix	that	were	degraded	by	cells.				
Image	processing	and	data	analysis		The	number	of	podosomes	was	quantified	automatically	by	applying	an	ImageJ-based	plugin	for	counting	nuclei	(ITCN)	to	images	of	the	podosome	core	(F-actin).		Quantification	was	validated	by	manual	analysis	of	the	first	5-10	cells	in	the	specimen.		The	automated	procedure	usually	detected	more	than	90%	of	the	podosomes	identified	by	manual	counting.	Line	intensity	profiles	(arbitrary	unit,	a.u.)	measuring	the	mean	intensity	of	GFP	or	mCherry	fluorescence	per	area	(µm2)	by	ImageJ	Plugin,	background-subtracted	and	normalized	per	maximal	intensity	in	the	field,	yielding	values	ranging	from	0	(lowest)	to	1	(highest).	For	the	measurement	of	the	area	of	focal	adhesions		visualized	by	fluorescently-labeled	paxillin	or	vinculin,	a	custom-written	software	(https://github.com/KanchanawongLab)	developed	in	Interactive	Data	Language	(IDL;	Harris	Geospatial	Inc.)	was	used	as	described	previously	54.	Briefly,	the	images	were	first	background	subtracted	using	the	Sternberg	rolling	ball	algorithm.	Subsequently,	focal	adhesions	were	segmented	using	Otsu	thresholding	algorithm.	The	software	determines	the	areas	of	individual	focal	adhesions.	The	total	area	of	focal	adhesion	per	cell	was	calculated	by	summing	the	values	of	individual	focal	adhesions.	Manual	curation	was	also	performed	to	exclude	segmented	non-FA	regions.		To	analyze	microtubules,	fluorescence	images	of	cells	labeled	by	mApple-MAP4	were	processed	as	described	previously	55.	The	enhanced	images	were	then	
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binarized	to	extract	the	microtubule	traces	by	a	threshold	calculated	using	Otsu's	method.	For	the	analysis	of	myosin-II	filaments	(labeled	by	GFP-MRLC)	and	F-actin	core	in	podosomes	(labeled	by	mCherry-UtrCH),	segmentation	was	performed	by	binarization	using	Otsu’s	threshold.	The	amounts	of	myosin-II,	MAP4	and	F-actin	were	computed	as	the	total	numbers	of	their	segmented	pixels.		
Gene	Expression	profile	The	transcriptomes	of	THP1	and	HT1080	were	mapped,	quantified	and	indicated	as	fragments	per	Kilobase	million	(FPKM)	using	the	RNA-Seq	technology.	Briefly,	the	total	RNA	of	THP1	and	HT1080	cell	lysates	was	extracted	using	the	RNeasy	Mini	Kit	(Qiagen)	according	to	manufacturer’s	protocol.	The	extracted	RNA	was	processed	and	analyzed	by	BGI	Tech	Solutions	Co.,	Ltd	(http://en.genomics.cn/index)	.		
Statistical	analyses	The	methods	for	statistical	analysis	and	sizes	of	the	samples	(n)	are	specified	in	the	results	 section	 or	 figure	 legends	 for	 all	 of	 the	 quantitative	 data.	 Differences	were	accepted	as	significant	for	P	<	0.05.	Prism	version	6	(GraphPad	Software)	was	used	to	plot,	analyze	and	represent	the	data.		The	quantitative	data	were	presented	in	the	figures	as	bar	graphs	or	scatter	dot	plots	showing	mean	±	SD,	or	box-and-whiskers	plots.	In	box-and-whiskers	plots,	whiskers	extend	from	the	minimum	to	maximum	values,	the	box	extends	from	the	25th	to	the	75th	percentile	and	the	line	within	the	box	represents	the	median.		
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Data	Availability	Statement		All	data	generated	or	analysed	during	this	study	are	included	in	this	published	article	(and	its	supplementary	information	files).	Raw	datasets	generated	during	and/or	analysed	during	the	current	study	are	available	from	the	corresponding	author	on	reasonable	request.			 	
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Figure	1:		
Effects	of	microtubule	uncoupling	 from	 integrin	adhesions	by	manipulations	
with	KANK	proteins	(A)	Control	HT1080	cell	show	microtubules	(a-tubulin,	green)	and	focal	adhesions	(paxillin,	 red).	 (B)	 Disruption	 of	 microtubules	 with	 1	 µM	 nocodazole	 augmented	focal	adhesion	size.	(C)	KANK	protein	domains:	Talin-binding	(KN),	coiled-coil	(CC),	and	ankyrin	repeats	(Ank).			(D)	Western	blots	showing	KANK1/2	levels	in	HT1080	cells;	 loading	 control,	 GAPDH.	 (E-F)	 Knockdowns	 of	 KANK1	 (E)	 or	 KANK2	 (F)	 in	HT1080	 cells	 increased	 focal	 adhesion	 size	 compared	 to	 control	 (A)	 but	 did	 not	disrupt	microtubules.	(G)	Microtubules	(green)	and	podosome	cores	(actin,	red)	in	control	THP1	cells.	 (H)	Disappearance	of	podosomes	upon	microtubule	disruption	with	 1	µM	 nocodazole.	 (I)	Western	 blots	 showing	 KANK1/2	 levels	 in	 THP1	 cells;	loading	 control,	a-tubulin.	 (J-K)	 Knockdowns	 of	 KANK1	 (J)	 but	 not	 KANK2	 (K)	 in	THP1	cells	induced	disassembly	of	podosomes	without	disruption	of	microtubules.	Co-localization	of	(L)	GFP-KANK1	and	(M)	GFP-KANK2	(green)	with	focal	adhesions	(mApple-paxillin,	 red)	 in	HT1080	 cells.	 (N)	Talin-binding	domain	of	KANK2	 (GFP-KANK2-KN,	 green)	 localized	 to	 paxillin-containing	 focal	 adhesions	 (red).	Localization	of	 (O)	GFP-KANK1	and	 (P)	GFP-KANK2	 (green)	 relative	 to	podosome	cores	(mCherry-UtrCH,	red)	in	THP1	cells.	 	(Q)	GFP-KANK1-KN	(green)	expression	reduced	 the	number	of	podosomes	and	augmented	 focal	adhesions-like	structures	(actin,	 red).	 Scale	 bars	 (A,	 B,	 E,	 F	 and	 L-N),	 10	 µm;	 (G,	 H,	 J,	 K	 and	 O-Q),	 5	 µm;	magnified	 images	 (L-Q),	 2	µm.	 (R-T)	 Quantitative	 changes	 in	 focal	 adhesions	 and	podosomes	in	cells	treated	as	indicated.	Each	condition	was	triple-repeated.	(R)	The	total	areas	of	focal	adhesions	(µm2)	per	cell	(n≥36	cells)	in	HT1080	cells.	(S-T)	The	podosome	numbers	 per	 cell	 in	 THP1	 cells	 (n≥70	 cells)	 are	 presented	 as	 box-and-whiskers	plots	(S)	and	the	percentage	of	cells	containing	≥10	podosomes	-	as	mean	±	SD	(T).	Nz-nocodazole.	p-values	calculated	using	two-tailed	Student’s	t-test.			 	
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Figure	 2:	 KANK	 proteins	 are	 required	 for	 targeting	 microtubules	 to	 focal	
adhesions	(A)	 Fluorescently-labeled	 fibronectin-coated	 islands	 (white)	 restricted	 localization	of	focal	adhesions	(B,	vinculin,	red)	in	HT1080	cells.	(C)	Control	and	(D)	KANK1	and	2	 knockdown	 cells	 showing	 microtubules	 (a-tubulin,	 green)	 and	 focal	 adhesions	(paxillin,	red).	The	cyan	dotted	circles	 in	C’	and	D’	correspond	to	adhesive	 islands.	Yellow	dotted	circles	mark	similar	areas	between	 the	adhesive	 islands.	Scale	bars,	10	µm.	(E)	The	ratios	of	the	numbers	of	microtubule	tips	overlapping	with	islands	containing	 focal	 adhesions	 versus	 circles	 without	 focal	 adhesions.	 Dots	 represent	control	 (n=21)	 or	 knockdown	 (n=23)	 cells	 (7-13	 islands/cell	 were	 assessed).	 p-value	 calculated	 using	 two-tailed	 Student’s	 t-test	 is	 indicated.	 	 (F)	 Control	 (n=21	cells)	 and	 (G)	KANK1+KANK2-depleted	 (n=18	 cells)	HT1080	 cells	displaying	EB3-decorated	 microtubule	 tips	 (mKO-EB3,	 green)	 and	 focal	 adhesions	 (GFP-vinculin,	red).	 Frames	 from	 time-lapse	 Supplementary	 Movies	 1	 and	 2,	 respectively.	 The	superimpositions	of	EB3	comet	images	from	the	boxed	areas	(60	frames	taken	every	second)	 are	 shown	 at	 high	 magnification	 in	 green	 and	 temporal	 color-code,	respectively.	 Each	 condition	 was	 repeated	 twice.	 Scale	 bars,	 10	 µm.	 (H-I-I’)	Transient	 disassembly	 of	 focal	 adhesions	 upon	 the	 enforced	 targeting	 of	microtubules.	 (H)	 A	 scheme	 depicting	 rapamycin-mediated	 formation	 of	 a	 link	between	two	parts	of	KANK1	molecule.	(I)	The	cell	triple-transfected	with	mApple-KN-FRB	(green),	FKBP-DKN-mEmerald	(red)	and	mTFP-vinculin	(black).	Rapamycin	(5	µg/ml)	triggered	localization	of	FKBP-DKN	to	KN-FRB-containing	focal	adhesions,	accompanied	by	gradual	disappearance	of	vinculin.	Typical	sequence;	27	cells	from	n=6	 experiments	were	 examined.	 Scale	 bar,	 10	µm.	 (I’)	 High	magnification	 of	 the	area	 boxed	 in	 (I).	 Scale	 bar,	 2	 µm.	 See	 Supplementary	 Movie	 4.	 (J)	 Decrease	 of	traction	forces	exerted	by	cell	(in	spectrum	scale)	upon	coupling	of	FKBP-DKN	and	KN-FRB	 after	 rapamycin	 addition.	 Typical	 sequence;	 10	 cells	were	 examined.	 The	cell	edges	are	marked	by	white	lines.	Scale	bar,	10	µm.	
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Figure	3:	Myosin-II	 filaments	mediate	 the	effect	of	microtubules	on	 integrin-
based	adhesions	(A	and	B)	Addition	of	1	µM	nocodazole	induced	the	assembly	of	numerous	myosin-II	filaments	 labeled	by	GFP-MRLC	 (green)	 in	THP1	 (A)	 and	HT1080	 (B)	 cells,	which	correlates	 with	 the	 disruption	 of	 podosomes	 (red)	 (A)	 and	 increase	 in	 focal	adhesion	 size	 (red)	 (B).	 Focal	 adhesions	 and	 podosome	 cores	 were	 marked	 by	mApple-paxillin	 and	 RFP-lifeact,	 respectively.	 	 Scale	 bars,	 5	 (A)	 and	 10	 (B)	 µm.	Graphs	A’	and	B’	show	the	changes	in	fluorescence	intensity	of	myosin-II	filaments	(green),	 podosomes	 (A’)	 and	 focal	 adhesions	 (B’)	 upon	microtubule	 disruption	 by	nocodazole.	 See	 Supplementary	 Movies	 5	 and	 6.	 For	 details	 of	 the	 quantification	procedures,	 see	 Materials	 and	 Method.	 (C-H)	 Effect	 of	 knockdown	 of	 myosin-IIA	heavy	chain	(MYH9)	in	THP1	cells.	(C)	Cells	transfected	with	control	siRNA	showed	circumferential	assembly	of	myosin-II	filaments	(green)	and	numerous	podosomes	visualized	by	actin	(red)	and	vinculin	(purple)	staining.	(D)	Knockdown	of	MYH9	led	to	complete	disappearance	of	myosin-IIA	filaments	but	did	not	affect	podosomes.	(E	and	 G)	 Microtubule	 disruption	 (E)	 or	 their	 uncoupling	 from	 podosomes	 by	endogeneous	 KANK1	 depletion	 (G)	 induced	 assembly	 and	 alignment	 of	 myosin-II	filaments	as	well	as	disruption	of	podosomes	and	 formation	of	 focal	adhesion-like	structures.	 (F	and	H).	Cells	 lacking	myosin-IIA	and	either	 treated	with	nocodazole	(F)	 or	 KANK1-depleted	 (H)	 preserved	 the	 podosomes	 and	 do	 not	 form	 focal	adhesions	Scale	bars,	5µm.	(I)	Western	blots	showing	KANK1	and	myosin-IIA	levels	in	cells	 treated	as	 indicated.	Loading	control,	a-tubulin.	Each	condition	was	 triple-repeated.	(J-L)	Quantification	of	the	podosome	numbers	per	cell	(box-and-whiskers	plots,	n≥57	cells)	(J),	percentage	of	cells	containing	≥10	podosomes	(mean	±	SD;	n=3	independent	 samples)	 (K)	 and	 area	 of	 focal	 adhesions	 (L)	 in	 cells	 treated	 as	indicated	 (n=10	 cells	 for	 each	 condition).	 Nz-nocodazole.	 The	 p-values	 calculated	using	two-tailed	Student’s	t-test	are	indicated.					
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Figure	 4:	 Recovery	 of	 functional	 podosomes	 in	 KANK1-depleted	 cells	 upon	
ROCK	inhibition	(A	 and	 A’)	 Podosome	 actin	 cores	 (RFP-lifeact,	 red)	 and	myosin-II	 filaments	 (GFP-MRLC,	green)	in	THP1	cell	before	(A)	and	after	(A’)	addition	of	30	µM	Y-27632.	See	Supplementary	 Movie	 12.	 (B	 and	 B’)	 KANK1-depleted	 cell	 shown	 before	 (B)	 and	after	(B’)	incubation	with	Y-27632.	Scale	bars,	5	µm.	See	Supplementary	Movie	15.	(C	and	D)	The	number	of	podosomes	(box-and-whiskers	plots,	n≥52	cells)	(C)	and	the	 percentage	 of	 cells	 containing	 ≥10	 podosomes	 (mean	 ±	 SD;	 n=3	 independent	samples)	(D)	in	cells	treated	as	indicated	(see	A,	B	and	Supplementary	Figure	7C-F).	Nz-nocodazole.	 CN03-RhoA	 activator.	 “Y-27632+Nz”	 represents	 pooled	 results	 of	experiments,	in	which	Y-27632	was	added	before	or	after	nocodazole.	The	p-values	calculated	using	two-tailed	Student’s	t-test	are	indicated.		(E-H)	Matrix	degradation	by	 recovered	podosomes.	Cells	were	 stained	 for	 actin	 (red)	 and	vinculin	 (purple),	while	matrix	degradation	is	seen	as	dark	areas	in	the	fluorescent	gelatin	substrates	(green).	(I-L)	Depletion	of	KANK1	abolishes	targeting	of	microtubules	to	podosomes	in	 THP1	 cells.	 The	 cells	 were	 plated	 on	 adhesive	 islands	 (as	 in	 Figure	 2A)	 for	ordered	localization	of	podosomes.	Microtubules	(a-tubulin,	green)	and	actin	(red)	were	labeled.	Upper	row	shows	z	projection	of	all	microtubules	and	actin	structures;	middle	and	 lower	rows	show	the	microtubules	and	actin	 in	 the	same	cell	 at	 z=0.4	
µm	and	z=0.0	µm	focal	planes,	respectively.	Microtubules	can	be	seen	at	 the	z=0.0	focal	plane	in	cells	transfected	with	control	siRNA	(I,	K)	but	not	in	cells	transfected	with	 KANK1	 siRNA	 (J,	 L).	 Scale	 bars,	 5µm.	 See	 quantification	 in	 Supplementary	Figure	8.	Each	condition	was	triple-repeated.		
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Figure	5:	Function	of	GEF-H1	 in	KANK-mediated	regulation	of	 integrin-based	
adhesions		(A-D)	Uncoupling	of	microtubules	from	integrin	adhesions	results	in	release	of	GEF-H1	 from	 microtubules	 in	 THP1	 cells.	 Vinculin	 (purple),	 GEF-H1	 (green)	 and	 a-tubulin	 (red)	 were	 visualized	 by	 immunofluorescence	 staining.	 In	 control	 cell,	vinculin	 labels	podosomes,	while	GEF-H1	 localizes	 to	microtubules	(A).	Disruption	of	microtubules	by	nocodazole	(B),	KANK1	knockdown	(C)	or	KANK1	displacement	by	 overexpression	 of	 KANK1-KN	 (D)	 resulted	 in	 diffuse	 GEF-H1	 distribution	 over	the	 entire	 cell.	 (E)	Western	blot	demonstrating	 siRNA-mediated	depletion	of	GEF-H1,	KANK1,	and	both	of	them	in	THP1	cells.	a-tubulin	is	used	as	loading	control.	(F-M)	Actin	(red)	was	visualized	by	phalloidin	staining	(F-K)	or	mCherry-UtrCH	(L,	M);	vinculin	 (purple)	 and	 myosin-IIA	 filaments	 (green)	 –	 by	 immunofluorescence	staining.	 GFP-KANK1-KN	 shown	 in	 cyan	 (L,	 M).	 Both	 control	 (F)	 and	 GEF-H1-depleted	(G)	cells	display	podosomes	and	peripheral	myosin-II	filaments.	Disruption	of	microtubules	(H,	I),	knockdown	of	KANK1	(J,	K)	and	overexpression	of	KANK1-KN	(L,	M)	resulted	 in	disappearance	of	podosomes	(and	 formation	of	 focal	adhesions)	as	well	as	massive	assembly	of	myosin-IIA	filaments	in	GEF-H1-containing		(H,	J,	L)	but	 not	 in	 GEF-H1	 depleted	 (I,	 K,	 M)	 cells.	 Scale	 bars,	 5	 µm.	 Each	 condition	 was	triple-repeated.	 (N-P)	 Quantification	 of	 the	 number	 of	 podosomes	 (box-and-whiskers	 plots,	 n≥80	 cells)	 (N),	 percentage	 of	 cells	 containing	 ≥10	 podosomes	(mean	 ±	 SD;	 n=3	 independent	 samples)	 (O),	 and	 average	 area	 of	 focal	 adhesions	(n=11	 cells	 for	 each	 condition)	 (P)	 in	 THP1	 cells	 treated	 as	 indicated.	Nz=nocodazole.	 The	 p-values	 calculated	 using	 two-tailed	 Student’s	 t-test	 are	indicated.				
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Figure	6:	Interplay	between	microtubules,	myosin-IIA	filaments,	and	integrin	
adhesions		Microtubules	 are	 coupled	 to	 integrin-containing	 adhesions	 via	 links	 formed	 by	KANK	 family	 proteins	 between	 integrin-binding	 protein	 talin	 and	 the	 cortical	microtubule	docking	complex	(liprins,	ELKS,	LL5b).	KANK	protein	binds	talin	via	KN	domain	 and	 liprin	 via	 coiled-coil	 domain.	 The	 microtubule	 docking	 complex	captures	 the	microtubule	plus	end	 through	 interaction	with	CLASP	proteins	 8.	The	guanine	 nucleotide	 exchange	 factor	 GEF-H1	 is	 associated	 with	 microtubules.	 Our	findings	 suggest	 that	 coupling	 of	 microtubules	 to	 integrin	 adhesions	 via	 KANK	suppresses	 GEF-H1	 ability	 to	 release	 from	 microtubules.	 In	 such	 situations,	 the	levels	of	Rho-GTP	and	activity	of	ROCK	are	low,	and	as	a	result,	only	few	myosin-IIA	filaments	are	located	in	the	proximity	of	adhesions.	Such	conditions	are	permissive	for	podosomes	but	 limit	 the	growth	of	 focal	adhesions.	Uncoupling	of	microtubule	tips	from	integrin	adhesions	by	depletion	or	displacement	of	KANK,	leads	to	release	of	 GEF-H1	 from	 microtubules,	 its	 activation,	 and	 consequent	 activation	 of	 the	Rho/ROCK	 signaling	 axis.	 As	 a	 result,	 the	 assembly	 of	 myosin-IIA	 filaments	 is	significantly	activated,	which	is	inimical	to	podosome	existence	but	favorable	for	the	formation	and	growth	of	stress	fiber-associated	focal	adhesions.			
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Supplementary notes 
Previous studies on dynamics of focal adhesions and podosomes and their 
regulation by microtubules 
Microtubule-driven alterations in cell-matrix adhesions are thought to be responsible for 
many microtubule-mediated changes in cell shape, polarization and migration 1-6. 
 
Several mechanisms were suggested to explain the regulation of focal adhesions by 
microtubules. These include functions of kinesin-1 7,8, Eg5 kinesin 9, MYPT1 and HDAC6 10, 
FAK and dynamin 11,12 and APC 13. In addition, microtubules were shown to be associated 
with Rho activator GEF-H1, and microtubule disruption results in activation of Rho/ROCK 
signaling axis 14-16. Moreover, growing microtubules are targeted to focal adhesions so that 
their plus ends form multiple transient contacts with these structures 7,17. 
 
Crosstalk between microtubules and podosomes was addressed in several studies. In 
particular, it was proposed that kinesins KIF1C 18,19 and KIF9 20, along with CLASPs 19,21 are 
involved in this regulation. 
 
Myosin-IIA filaments are required for maturation and integrity of focal adhesions 22-28. At the 
same time, activation of myosin-IIA by a number of pathways promote podosome turnover 
and disassembly 29-33. Involvement of myosin-IIA filaments in microtubule-dependent 
regulation of focal adhesions and podosomes require further investigation.  
 
Additional information on constructs used in this study 
Expression vectors for fluorescent protein fusion constructs were kindly provided by several 
laboratories, as follows: EGFP-KANK1, EGFP-KANK1-KN, EGFP-KANK1ΔANKR and 
EGFP-KANK1 CC-Cter 34 from Dr. Anna Akhmanova (Utrecht University, Utrecht, The 
Netherlands); EGFP-KANK2, EGFP-KANK2-KN, EGFP-KANK2 (1-670) and EGFP-
KANK2ΔKN 35, from Dr. Reinhard Fässler (Max Planck Institute of Biochemistry, Germany); 
GFP-Vinculin, mCherry-Vinculin, mTFP-vinculin, mApple-MAP4, mKO-EB3, GFP-paxillin 
and mApple-Paxillin from Dr. Michael W. Davidson (Florida State University, FL, USA); 
GFP-RhoAQ63L, from Dr. Clare M. Waterman (National Institutes of Health, USA); FLAG-
ROKα1-543, from Dr. Ronen Zaidel-Bar (Mechanobiology Institute, Singapore); human 
GFP-Myosin regulatory light chain (MRLC), from Dr. Mark Dodding (King’s College London, 
49
UK). Microtubule-binding domain of E-MAP-115/ensconsin (GFP-ensconsin) 36; RFP-Zyxin 
37, mouse GFP-MRLC 38, mCherry-UtrCH 39, RFP-Lifeact and GFP--actin 31 were 
described previously.  
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Supplementary Figure 1 
Supplementary results on the localization and functions of KANK1 and KANK2. (A) 
Localization and dynamics of GFP-KANK1 at podosomes in THP1 cell. Six columns (from 
left to right) represent the sequence of podosome images taken at 3 minute-intervals for 15 
minutes. Labeling by mCherry-vinculin (red), GFP-KANK1 (green) and their merged images 
are shown. Graph on the right represents the line scan profile of vinculin (red) and KANK1 
(green) across the podosome shown in the third column (6th minute). KANK1 is located to 
the outer ring surrounding the vinculin ring of podosome. (B) Effects of knockdown of 
KANK1 and KANK2 on THP1 cells projected area (m2). KANK1 knockdown slightly 
decreases cell size while KANK2 knockdown markedly increased it. Each dot corresponds to 
individual cell (mean ± SD; n≥23 cells for each condition). The p-values calculated using 
two-tailed Student’s t-test are indicated.  Each condition was triple-repeated. (C) KANK1 and 
KANK2 double knockdown in HT1080 cell labeled with -tubulin (green) and paxillin (red) 
antibodies. The cell preserved well-developed microtubule network (left) and form large focal 
adhesions (right). The measurements of focal adhesion area are shown in Figure 1R. 
Images are representative of n≥3 independent experiments. (D) Overexpression of talin-
binding GFP-KANK1-KN in HT1080 cell resulted in displacement of endogenous KANK2 
from the focal adhesions. Two cells labeled with antibody against KANK2 (red) are shown. 
GFP-KANK1-KN (green) is expressed only in the upper cell (shown in the right image). Note 
that the lower cell which does not express GFP-KANK1-KN displays prominent KANK2-
positive focal adhesions while the upper cell expressing GFP-KANK1-KN contains less of 
endogenous KANK2 in focal adhesions. Images are representative of two independent 
experiments.  (E) Localization of talin-binding GFP-KANK1-KN domain (green) to focal 
adhesions marked by mApple paxillin (red) in HT1080 cell. The enlarged images of boxed 
focal adhesion (E’) demonstrate that KANK1-KN labeling overlapped with that of paxillin at 
the focal adhesion (merged image). Scale bars in C-E, 10 μm; magnified images in E, 2 μm. 
Images are representative of n≥3 independent experiments. (F) Overexpression of GFP-
KANK2-KN (green) in THP1 cell. The actin is labeled by mCherry-UtrCH (red). KANK2-KN 
resulted in total disruption of podosomes and appearance of focal adhesion-like structures 
containing KANK2-KN. Scale bar, 5m. (F’) The enlarged images of boxed areas showing 
localization of GFP-KANK2-KN, actin and their merge. Scale bar, 2 m.  
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Supplementary Figure 2 
Effects of microtubule disconnection from integrin adhesions in different cell types. 
(A-D) Podosome-forming murine RAW 264.7 macrophages. (A) Localization of GFP-KANK1 
(green) and F-actin labeled by mCherry-UtrCH (red) in phorbol 12-myristate 13-acetate 
(PMA)-stimulated RAW 264.7 cell. GFP-KANK1 localized to the adhesive rings surrounding 
the actin cores of podosomes and in focal adhesion-like structures at the cell periphery 
(merged image). (B) Cell overexpressing GFP-KANK1-KN (green) did not form podosomes 
and display prominent KN-positive focal adhesion-like structures upon stimulation with PMA. 
Actin is labeled by mCherry-UtrCH (red). Scale bars, 5 m. Each condition was triple-
repeated. (C) The number of podosomes per cell in control and KN-overexpressing cells 
(box-and-whiskers plots; n≥26 cells for each condition). (D) The average areas of focal 
adhesion-like structures in control and KN-overexpressing cells visualized by GFP-KANK1 
and GFP-KANK1-KN, respectively (box-and-whiskers plots; n=8 cells for each condition). (E-
H) Human colon adenocarcinoma cell line HT-29.  Immunofluoresence labeling of myosin-
IIA heavy chain (MHC-IIA) (green) and focal adhesions labeled by paxillin (red) in untreated 
(E), nocodazole-treated (F), and GFP-KANK2-KN (purple) overexpressing cells (G). Both 
disruption of microtubules and their disconnection from integrin adhesions by GFP-KANK2-
KN overexpression resulted in increase of myosin-IIA filaments number and focal adhesion 
size. Nz=nocodazole. Scale bars, 5 m. (H) The quantification of total focal adhesion area 
per cell (box-and-whiskers plots; n≥23 cells for each condition; three independent 
experiments). (I-K) Human umbilical vein endothelial cells (HUVECs).  F-actin labeled by 
mCherry-UtrCH (red) and focal adhesions labeled by mTFP-vinculin (purple) in control (I) 
and GFP-KANK1-KN (green) overexpressing (J) cells. Each condition was triple-repeated. 
(K) Overexpression of GFP-KANK1-KN induced increase in average focal adhesion area 
(n=12 cells for each condition). Scale bars, 10 m. In C, D, H and K, the p-values calculated 
using two-tailed Student’s t-test are indicated.   
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Supplementary Figure 3 
Liprin-binding coiled coil domain of KANK1 is responsible for the differential effect of 
KANK1 and KANK2 on podosomes in THP1 cells. (A) A diagram depicting the domain 
structures of KANK1, KANK2, and a chimeric protein KANK2/CC-KANK1, designed as 
KANK2, in which the liprin-binding coiled-coil domain was replaced by that of KANK1. In 
particular, the residues 188-238 of KANK2 corresponding to its coiled-coil domain 35 were 
substituted with the residues 257-500 of KANK1 corresponding to its coiled-coil domain 34. 
(B-E) The effects of expression of full-length KANK2 and KANK2/CC-KANK1 on podosomes 
in THP1 cells containing or lacking KANK1. (B) Expression of GFP-KANK2 (green) in cell 
transfected with control siRNA did not affect podosomes labeled by mCherry-UtrCH (red). 
GFP-KANK2 is poorly localized to podosomes. (C) GFP-KANK2/CC-KANK1 strongly 
localize to podosomes in cell transfected with control siRNA. (D) Expression of GFP-KANK2 
(green) in KANK1-depleted cell did not rescue podosomes. (E) Expression of GFP-
KANK2/CC-KANK1 in KANK1-depleted cell rescued podosomes. The GFP-KANK2/CC-
KANK1 is localized to the rescued podosomes. Scale bars, 5m. Each condition was 
repeated twice. (F) Quantification of the effect of full-length GFP-KANK2 and GFP-
KANK2/CC-KANK1 on podosome number in control and KANK1 knockdown cells (box-and-
whiskers plots; n≥25 cells for each condition). KANK2/CC-KANK1 but not full-length KANK2 
expressions significantly increased the podosome number in KANK1-depleted cells. The 
average number of podosomes in KANK1-depleted cells expressing KANK2/CC-KANK1 was 
however still lower than in cells containing KANK1. The p-values calculated using two-tailed 
Student’s t-test are indicated.   
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Supplementary Figure 4 
Rescuing the phenotypes of KANK1 and KANK2-depleted cells by the respective 
deletion mutants. (A) A diagram depicting the domain structures of KANK1 and presenting 
its deletion mutants as described in Ref 34. (B-E) KANK1 depleted THP1 cells. In each triple 
panel, the images of podosome cores visualized by actin labeling with mCherry-UtrCH (red), 
localization of GFP fusion constructs of KANK1 or its deletion mutants (green), and the 
merged images are shown. (B and C) Full-length GFP-KANK1 (B) and GFP-KANK1ANKR 
(C) rescued podosomes in the KANK1-depleted cells.  (D and E) GFP-KANK1-KN (D) and 
GFP-KANK1-CC-Cter (E) did not rescue podosomes in KANK1-depleted cells. Scale bars, 5 
m. Each condition was triple-repeated. (F) A  diagram depicting the domain structures of 
KANK2 and its deletion mutants as described in Ref 35.  Putative binding domain for KIF21A 
is indicated by analogy with KANK1. (G-J) KANK2 depleted HT1080 cells. In each triple 
panel, the images of focal adhesions visualized by paxillin antibody staining (red), 
localization of GFP fusion constructs of KANK2 or its deletion mutants (green), and the 
merged images are shown. Full-length GFP-KANK2 (B) and GFP-KANK2 (1-670) (C) 
demonstrate focal adhesions of normal size while GFP-KANK2-KN (D) and GFP-
KANK2KN (E) show large focal adhesions similarly to KANK2-depleted cells (See Figure 
1F). Each condition was triple-repeated. Scale bars, 10 m. (K, L) The number of 
podosomes per cell (box-and-whiskers plots; n≥30 cells for each condition) (K) and 
percentage of cells with ≥10 podosomes (mean  SD; n=3 independent samples). (L) in 
THP1 cells treated as indicated are presented as box-and-whiskers and mean ± SD, 
respectively. The data on control siRNA + GFP-KANK1-transfected cells and KANK1 siRNA-
transfected cells are the same as in Figure 1S and 1T and represent the pooled results of 6 
and 7 experiments, respectively. The other data represent the pooled results of not less than 
3 independent experiments. (M) The total focal adhesion areas per cell in HT1080 cells 
treated as indicated are presented. The data on control siRNA and KANK2 siRNA-
transfected cells are the same as in Figure 1R and represent the pooled results of three 
independent experiments (box-and-whiskers plots; n≥24 cells for each condition). The p-
values calculated using two-tailed Student’s t-test are indicated in all graphs.   
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Supplementary Figure 5 
Myosin-IIA but not myosin-IIB knockdown abolished effect of microtubule 
disruption/disconnection on integrin-based adhesions. (A) Western blot data showing 
depletion of myosin-IIA and KANK2 in HT1080 cells upon transfection with specific siRNAs. 
-tubulin was used as loading control. (B) Each column represents the individual myosin-IIA 
knockdown HT1080 cell treated as indicated. The microtubules were labeled with -tubulin 
antibody staining (green) and focal adhesions in the same cells with antibody to paxillin 
(red). The focal adhesion size in myosin-IIA knockdown cell is small and did not change 
upon microtubule disruption by nocodazole or outgrowth after nocodazole washout. (C) 
Myosin-IIA knockdown abolished the effect of KANK2 knockdown on focal adhesion size. 
The cells were labeled with myosin-IIA heavy chain (green) and paxillin (red) antibodies. 
KANK2 knockdown cell showed augmented focal adhesions and myosin-II filaments, while 
double myosin-IIA and KANK2 knockdown cell demonstrated reduced focal adhesion size. 
(D) Western blot data showing depletion of myosin-IIB in HT1080 cells upon transfection 
with MYH10 siRNA. -tubulin was used as loading control. (E) Myosin-IIB knockdown did 
not prevent increase of focal adhesion size in nocodazole-treated cell. The cells were 
labeled with antibodies to myosin-IIA and paxillin as in (C). Note that knockdown of myosin-
IIB by itself increased the amount of myosin-IIA filaments and the areas of focal adhesions. 
However, the nocodazole treatment significantly increased the total area of focal adhesions 
in cells transfected with either control or myosin-IIB siRNA. Images are representative of two 
independent experiments. Scale bars in B, C and E, 10 m. (F) Quantification of the results 
shown in (E). Total areas of focal adhesions per cells in cells treated as indicated are shown 
(box-and-whiskers plots; n≥40 cells for each condition) as box-and-whiskers plot. (G-J) 
THP1 cells labeled by phalloidin to visualize actin (red), and by myosin-IIA (green) and 
myosin-IIB (purple) heavy chain antibodies. (G) Cell transfected with control siRNA, 
demonstrated numerous actin-positive podosomes and peripherally localized myosin-IIA and 
myosin-IIB containing filaments. (H) The knockdown of myosin-IIB affected neither 
podosomes nor myosin-IIA-containing filaments. (I) KANK1 knockdown disrupted 
podosomes and induced formation of actin bundles and myosin-IIA filament stacks. The 
distribution of myosin-IIB essentially followed that of myosin-IIA. (J) The double knockdown 
of KANK1 and myosin-IIB led to complete disruption of podosomes and enhancement of 
actin bundles and myosin-IIA filament stacks. Scale bars, 5 m. Each condition was 
repeated twice. (K) Quantification of podosomes number in cells (box-and-whiskers plots; 
n≥35 cells for each condition) treated as indicated in (G-J). Nz=nocodazole. The p-values 
calculated using two-tailed Student’s t-test are indicated in both graphs.   
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Supplementary Figure 6 
Enhancement of microtubule targeting to focal adhesions brings about disassembly 
of myosin-II filaments and focal adhesions. (A) Time-lapse observations of microtubules 
(upper row), computationally segmented microtubules (second row) and myosin-II filaments 
(bottom row) in the course of microtubule outgrowth after nocodazole washout in HT1080 
cell. Time after the nocodazole washout is indicated in each frame.  Microtubules and 
myosin-II filaments were labeled by mApple-MAP4 and GFP-MRLC, respectively. Inverted 
images of microtubule labeling are shown. Note that recovery of microtubules is 
accompanied by disappearance of myosin-II filaments. See Supplementary Movie 7. (B) 
Quantification of the changes in fluorescence intensity of microtubules (red) and myosin-II 
filaments (green) shown in (A). For details of the quantification procedures, see Materials 
and Method. (C) Changes in traction forces exerted by cell in the course of microtubule 
recovery following nocodazole washout. The traction forces are presented in the upper row 
in spectrum scale shown on the right. The corresponding images of cells with focal 
adhesions labeled with RFP-zyxin are presented in the bottom row, along with the time in 
minutes after nocodazole washout. The traction forces and focal adhesion size strongly 
decreased following nocodazole washout but recovered in about 20 minutes thereafter. See 
Supplementary Movie 8. (D) Changes in sum of the absolute values of traction forces (kPa) 
and total focal adhesion area (m2) per cell shown in (C). The drop and subsequent increase 
of traction forces (red) preceded the drop and increase in focal adhesion area (blue). (E) 
KANK2 knockdown suppresses the effect of microtubule outgrowth on the amount of 
myosin-II filaments. Microtubules (upper row), computationally segmented microtubules 
(second row), myosin-II filaments (bottom row) in the same cell were labeled as indicated in 
(A). Time after nocodazole washout is indicated in the upper row. See Supplementary Movie 
9. Note that in spite of microtubule outgrowth, the decrease of myosin-II filament 
fluorescence was less pronounced than in control cell shown in (A). (F) Quantification of the 
changes in fluorescence intensity of microtubules (red) and myosin-II filaments (green) as in 
(B). Nz-nocodazole. Sequences shown in (A-F) are representative of n≥3 independent 
experiments. Scale bars in all panels correspond to 10 m. (G) Changes in the total area of 
focal adhesions after nocodazole treatment and washout in control and KANK2 knockdown 
cells shown as box-and-whiskers plots (n≥40 cells for each condition). The cells treated as 
indicated were fixed and stained with paxillin antibody to visualize focal adhesions. The p-
values calculated using two-tailed Student’s t-test are indicated.  
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Supplementary Figure 7 
Microtubule disruption or disconnection from integrin adhesions affect the adhesions 
via activation of RhoA-ROCK axis. (A and B) Results of pull-down assays showing effects 
of KANK1 and KANK2 knockdowns on RhoA activation in HT1080 and THP1 cells as 
compared to the effects of nocodazole treatment. Western blots of RhoA-GTP level and of 
total RhoA in the corresponding samples are shown in the upper and lower rows, 
respectively. (A’ and B’) The ratios between the amounts of RhoA-GTP to total RhoA in the 
sample estimated as a ratio between intensities of corresponding bands. The results 
normalized to the value of such ratio in untreated cells transfected with control siRNA are 
presented in the graphs. Each treatment was assessed by triplicate measurements. The 
mean values are indicated as horizontal bars.  (A, A’) The knockdown of either KANK1 or 
KANK2 in HT1080 cells led to 2-fold increase of average RhoA-GTP level as compared to 
control, similar to nocodazole treatment. The differences between KANK1 and KANK2 
knockdown effects as compared to that of nocodazole are non-significant. (B, B’) The 
knockdown of KANK1 but not KANK2 in THP1 cells led to increase of RhoA-GTP level 
similar to nocodazole treatment. Each condition was triple-repeated. The p-values calculated 
using two-tailed Student’s t-test are indicated in both A’ and B’ graphs (mean ± SD; n=3 
independent experiments). (C-F) Podosomes were visualized by RFP-lifeact (red) and 
myosin-II filaments were labeled by GFP-MRLC (green) in THP1 cells. (C, C’) Effect of RhoA 
activation.  Podosomes and myosin-II filaments in the same cell before (C) and 36 minutes 
following (C’) addition of Rho activator, CN03. Note the assembly of new myosin-II filaments 
and the disappearance of podosomes. See Supplementary Movie 10. (D, D’) DMSO, control. 
Merged images of podosomes and myosin-II filaments before (D) and after (D’) incubation 
with DMSO. See Supplementary Movie 11. (E-K) ROCK inhibition prevents the effect of 
nocodazole. (E, E’) Cell was pre-treated with Y-27632 for 30 minutes before addition of 
nocodazole at 0 minute (E) and further incubated in the presence of both compounds for 36 
minutes (E’). Treatment with Y-27632 disrupted myosin-II filaments and prevent disruptive 
effect of nocodazole on podosomes (cf. Figures 1H and 3A). See Supplementary Movie 13. 
(F, F’) Cell pre-treated with nocodazole for 30 minutes before addition of Y-27632 at 0 
minute (F) and further incubated in the presence of both compounds for 34 minutes (F’). 
Addition of Y-27632 resulted in the disassembly of myosin-II filaments, and subsequent 
recovery of podosomes. See Supplementary Movie 14. Each condition was triple-repeated. 
See quantification of effects shown in C-F in Figures 4C and D. (G-K) Inhibition of ROCK by 
thiazovivin. (G-J) The actin cores and adhesive rings of podosomes were visualized by 
staining of F-actin by phalloidin and vinculin by corresponding antibody. Myosin-II filaments 
were stained by antibody to myosin-IIA heavy chain. (G) DMSO-treated cell (control); (H) 
Cell treated with nocodazole (Nz) for 1 hour; note the disruption of podosomes, appearance 
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of focal adhesion-like structures (arrowheads) and burst of myosin-II filament assembly. (I) 
Treatment with ROCK inhibitor thiazovivin for 1hour disrupted myosin-II filaments. (J) Cell 
pre-treated with thiazovivin for 30 minutes and further incubated with nocodazole and 
thiazovivin for 1 hour demonstrated intact podosomes. Scale bars in C-J, 5 m. Each 
condition was repeated twice. (K) Box-and-whiskers plots showing the numbers of 
podosomes per cell (n≥40 cells for each condition) indicated in G-J. (L-N) Constitutively 
active RhoA and ROCK1 prevented the disruption of focal adhesions following microtubule 
outgrowth in HT1080 cells.  (L) Time-lapse sequences showing focal adhesion dynamics 
after nocodazole washout in control cell (top row), cell expressing constitutive active RhoA-
Q63L (middle row) and cell expressing dominant active ROCK (rat Rok-alpha 1-543aa). The 
focal adhesions labeled by mApple-paxillin were visualized by TIRF microscopy. The cells 
were pre-treated with nocodazole for 1 hour. Nocodazole washout led to disassembly of the 
focal adhesions, while constitutively active RhoA and ROCK prevented this process. Images 
are representative of two independent experiments. Scale bars, 10 m.  See Supplementary 
Movie 16. (M) Intensities of mApple-paxillin fluorescence in focal adhesions (n≥34 for each 
condition; mean ± SEM) normalized to the intensity level in the first frame, in control, RhoA-
Q63L expressing and ROCK1-DA expressing cells shown in (L). (N) Total area of focal 
adhesions per cell visualized by paxillin antibody staining in control and RhoA-Q63L 
expressing cells are shown in box-and-whiskers plots. The cells were either untreated, 
nocodazole-treated for 1 hour, or fixed after 30 minutes following nocodazole washout. Nz-
nocodazole. n≥14 cells from two independent experiments were measured for each type of 
treatment. The p-values calculated using two-tailed Student’s t-test are indicated.   
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Supplementary Figure 8 
Quantification of the localization of microtubule tips to the podosomes or focal adhesion-like 
structures in THP1 cells plated on micropatterned adhesive islands (see Figure 4I-L). (A) 
Percentage of adhesive islands with microtubule tips seen at z=0 focal plane. Each dot corresponds to 
individual cell (n=30 cells were scored for each type of treatment).  The mean  SD values are shown. 
The p-values calculated using two-tailed non-parametric Mann–Whitney test are indicated. (B) The 
histograms representing fractions of the cells having the lowest microtubule tips at indicated focal planes 
(n≥56 cells were scored for each type of treatment). 
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Supplementary Figure 9 
Function of GEF-H1 in different cell types. (A-G) Release of GEF-H1 from 
microtubules upon microtubule disruption or disconnection from focal adhesions. (A-
D) Focal adhesions (vinculin, purple), GEF-H1 (green) and microtubules (-tubulin, red) 
were labeled by corresponding antibodies in HT1080 cells. (A) Control cell formed peripheral 
focal adhesion; GEF-H1 was localized to microtubules. (B) Disruption of microtubules by 
nocodazole (Nz) treatment for 1 hour resulted in augmentation of focal adhesions and 
diffused localization of GEF-H1. (C and D) KANK2 knockdown (C) or KANK1 and KANK2 
double knockdown (D) resulted in appearance of larger and non-peripherally localized focal 
adhesions (cf. Figure 1 and Supplementary Figure 1) and diffused localization of GEF-H1.  
Microtubule network is apparently intact in C and D. Images are representative of three 
independent experiments. (E) Western blot analysis of KANK1 levels in human endothelial 
cells (HUVECs) transfected with control and KANK1 siRNAs. -tubulin was used as the 
loading control. (F and G) Microtubules (white) and GEF-H1 (green) visualized by -tubulin 
and GEF-H1 antibodies, respectively, in cells transfected with control siRNA (F) and KANK1 
siRNA (G). Depletion of KANK1 resulted in diffused GEF-H1 localization.  Scale bars, 10m. 
Each condition was repeated twice. (H-M) Effect of GEF-H1 knockdown in THP1 cells (data 
supplementary to Figure 5E-P). Actin (red), myosin-IIA filaments (green) and microtubules 
(white) were visualized by staining with phalloidin, myosin-IIA heavy chain and -tubulin 
antibodies, respectively. Control (H) and GEF-H1 knockdown (I) THP1 cells demonstrated 
intact podosomes cores, peripheral myosin-II filaments and well-developed microtubule 
arrays. (J and K) Nocodazole (Nz) treatment for 1 hour disrupted podosomes and enhanced 
the amount of myosin-II filaments in control (J) but not in GEF-H1 knockdown (K) cells, even 
though the disruption of microtubules was complete in both cases. (L and M) KANK1 
knockdown led to disassembly of podosomes and increase in the amount of myosin-IIA 
filaments (L) but cells lacking both GEF-H1 and KANK1 demonstrated intact podosomes and 
low level of myosin-II filaments (M). The microtubules are well preserved in both cases.  
Each condition was repeated twice. Scale bars, 5 m. 
 
  
68
GF
B
0 1 2 3 4 5
0.0
0.5
1.0
Time after nocodazole washout (min)
To
ta
l a
m
ou
nt
 (n
or
m
al
iz
ed
) Microtubule
MyosinLC
Vinculin
Vinculin
KANK2 siRNA
Control siRNA
H
A
I
KANK2
GEF-H1
α-tubulin
co
ntr
ol 
siR
NA
KA
NK
2 s
iR
NA
GE
F-
H1
 si
RN
A
KA
NK
2 s
iR
NA
 +
 G
EF
-H
1 s
iR
NA
0 min 0.5 min 1 min 2 min 5 min
Microtubule
Vinculin
Nocodazole washoutGEF-H1 siRNA
GFP-MRLC
Paxillin GFP-KANK2-KN
Control siRNA GEF-H1 siRNA
Paxillin GFP-KANK2-KN
J K
E
GEF-H1 siRNA
GEF-H1 siRNA + KANK2 siRNA
MicrotubulePaxillin
MicrotubulePaxillin
D
Paxillin
Paxillin
Microtubule
Microtubule
C
50 kDa
100 kDa
100 kDa
135 kDa
co
ntr
ol 
siR
NA
1µ
M 
Nz
Nz
 w
as
ho
ut
GE
F-H
1 s
iR
NA
GE
F-H
1 s
iR
NA
 + 
1µ
M 
Nz
GE
F-H
1 s
iR
NA
 + 
Nz
 w
as
ho
ut
0
50
100
150
To
ta
l F
A
 a
re
a 
/ C
el
l (
μm
2 ) p < 0.0001
p < 0.0001 p < 0.0001
p = 0.0012 p = 0.0346
co
ntr
ol 
siR
NA
GE
F-H
1 s
iR
NA
KA
NK
2 s
iR
NA
GE
F-H
1 s
iR
NA
 + 
KA
NK
2 s
iR
NA
Co
ntr
ol 
siR
NA
 + 
KA
NK
2-K
N
GE
F-H
1 s
iR
NA
 + 
KA
NK
2-K
N
0
50
100
150
To
ta
l F
A
 a
re
a 
/ C
el
l (
μm
2 )
p < 0.0001
p = 0.0068
p < 0.0001
p = 0.4730
p = 0.5745
69
Supplementary Figure 10 
GEF-H1 knockdown prevented the effects of microtubule disconnection from focal 
adhesions and microtubule outgrowth on focal adhesions in HT1080 cells. (A) Western 
blot demonstrating siRNA-mediated depletion of GEF-H1, KANK2, and both of them in 
HT1080 cells. α-tubulin is used as loading control. (B-E) Focal adhesions (paxillin, red) and 
microtubules (-tubulin, green) in HT1080 cells transfected with control (B), GEF-H1-
targeted (C), KANK2-targeted (D) siRNAs, or with both KANK2- and GEF-H1- targeted 
siRNAs (E). KANK2 knockdown increased the size of focal adhesions in control but not in 
GEF-H1 knockdown cell. The integrity of microtubules was not affected in any cases. (F and 
G) GEF-H1 knockdown prevented increase in focal adhesion area induced by expression of 
GFP-KANK2-KN. (F) Cell transfected with control siRNA and GFP-KANK2-KN (green) 
demonstrates large and numerous paxillin-positive focal adhesions (red) containing KANK2-
KN. (G) The cell transfected with GEF-H1 siRNA and GFP-KANK2-KN has lower total focal 
adhesion area, similarly to cells transfected with GEF-H1 siRNA alone (see C). Images are 
representative of two independent experiments. Scale bars, 10 m. (H) Quantification of the 
total focal adhesion area per cell in conditions corresponding to that shown in box-and-
whiskers plots (B-G). n≥20 cells from two independent experiments were measured for each 
type of treatment.  (I) The sequence of images showing the GEF-H1 knockdown cell labeled 
for microtubules (upper panels), myosin-II filaments (middle panels) and focal adhesions 
(bottom panels) in the course of microtubule outgrowth after nocodazole washout. The 
microtubules, myosin-II filaments and focal adhesions were labeled with mApple-MAP4, 
GFP-MRLC and mTFP-vinculin, respectively. See Supplementary Movie 17. The images of 
microtubules and focal adhesions are reversed. Unlike the strong disruptive effect of 
microtubule outgrowth on myosin-II filaments and focal adhesions in control cells (cf. 
Supplementary Figure 6A and B), the recovery of microtubules in GEF-H1 knockdown cell 
was accompanied by only partial disruption of myosin-II filaments and focal adhesions (see 
quantification in J). Scale bar, 10 m. (J) The dynamics of total fluorescence intensity of the 
microtubules, myosin-II filaments and focal adhesions in cell shown in (I) is presented in 
blue, green and red plots, respectively. Images and graph are representative of two 
independent experiments. (K) The measurements of total focal adhesion area per cell in 
control and GEF-H1 knockdown cells upon nocodazole treatment and washout are shown in 
box-and-whiskers plots. n60 cells were assessed for each type of treatment from three 
independent experiments. The cells were fixed and stained with antibodies to paxillin after 
respective treatments. Nz=nocodazole. The p-values calculated using two-tailed Student’s t-
test are indicated.   
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Supplementary Figure 11 
Verification of the effects of Dharmacon smartpool siRNAs against myosin-IIA and 
GEF-H1 in experiments with individual siRNAs. (A) Western blot data showing effects of 
individual siRNAs on myosin-IIA heavy chain (MYH9) expression in HT1080 cells. The 
information corresponding to individual siRNAs (#05-#08) is presented in Materials and 
Methods. -tubulin was used as loading control. (B) Cell transfection with myosin-IIA siRNA 
#05 prevented the effects of nocodazole and nocodazole washout on focal adhesions in 
HT1080 cells. Focal adhesions (red) and microtubules (green) were immunolabeled with 
paxillin and -tubulin antibodies, respectively. Images are representative of two independent 
experiments. Scale bar, 10 m. (C-H) Myosin-II siRNAs #05 and #08 prevented the 
disruption of podosomes upon addition of nocodazole in THP1 cells. Cells transfected with 
indicated siRNAs were labeled for actin by phalloidin (red) to visualize podosomes, and 
immunostained for myosin-IIA heavy chain (green) and -tubulin (white) to visualize myosin-
IIA filaments and microtubules, respectively. (C and D) Treatment with nocodazole of cells 
transfected with control siRNA resulted in disappearance of podosomes and formation of 
numerous myosin-II filaments. (E-H) Transfection of THP1 cells with either myosin-IIA siRNA 
#05 (E and F) or #08 (G and H) abolished effect of nocodazole on podosomes in spite of 
disruption of microtubules. The effects of individual siRNAs #05 and #08 did not differ from 
the effect of Dharmacon smartpool presented in Figure 3 and Supplementary Figure 5. 
Scale bars, 5 m. Each condition was repeated twice. (I and J) Individual siRNA to GEF-H1 
(#09) abolished the effect of nocodazole and KANK2 knockdown on focal adhesions in 
HT1080 cells. (I) Western blot showing the effect of individual siRNA #09 on GEF-H1 
expression in control and KANK2 knockdown cells. -tubulin was used as a loading control. 
(J) Total focal adhesion area in control, nocodazole (Nz)-treated and KANK2-depleted 
HT1080 cells, nontransfected or transfected with GEF-H1 siRNA #09 (box-and-whiskers 
plots; n≥40 cells for each condition in two independent experiments). The GEF-H1 siRNA 
#09 prevented the increase of focal adhesion area by nocodazole or KANK2 depletion 
similarly or stronger to the Dharmacon smartpool against GEF-H1 as shown in 
Supplementary Figure 10.  The information corresponding the GEF-H1 siRNA #09 is 
presented in Materials and Methods. The p-values calculated using two-tailed Student’s t-
test are indicated.   
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Supplementary Figures 12 
Uncropped images of western blots of HT1080 cells showed in Figure 1D (A), 
Supplementary Figure 5A (B), Supplementary Figure 7A (C) and Supplementary Figure 10A 
(D). See detailed explanation in the legends to the corresponding figures. The boxed areas 
(blue frames) show the cropped images.     
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Supplementary Figure 13 
 
Uncropped images of western blots of THP1 cells showed in Figure 1I (A and B), Figure 3I 
(C) and Figure 5E (D). See detailed explanation in the legends to the corresponding figures. 
The boxed areas (blue frames) show the cropped images.          
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Supplementary Table 1 
 
Gene expression profile of HT1080 and THP1 cells presented as fragments per kilobase million 
(FPKM) values. See materials and method section for details of the quantification.   
 
Gene ID Protein FPKM values  
  HT1080 THP1 
23189 
 
KANK1 
 
5.46 
 
6.74 
 
25959 
 
KANK2 18.6 
 
71.97 
 
256949 
 
KANK3 
 
0.46 
 
0.23 
 
163782 
 
KANK4 
 
1.37 
 
- 
 
23332 
 
CLASP1 8.37 
 
10.23 
 
3688 
 
Integrin 1 
 
547.88 
 
69.23 
 
3689 
 
Integrin 2 
 
0.61 217.96 
 
7094 
 
Talin-1 98.26 
 
80.24 
 
7414 
 
Vinculin 81.37 
 
22.35 
 
8496 
 
Liprin-1 
 
65.6 
 
8.29 
 
60 
 
-actin 3876.02 
 
4328.99 
 
999 Cadherin-1 0.15 0.67 
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Supplementary movie legends 
 
 
Supplementary movie 1 
The microtubule plus ends of HT1080 cell transfected with control siRNA are 
accumulated at focal adhesions concentrated within adhesive islands  
  
Cell with focal adhesion labeled with GFP-vinculin (red) and microtubule plus tips labeled 
with mKO-EB3 (green) was imaged using SIM. Single plane close to the substrate is shown. 
The frames were recorded at 1-second intervals over a period of 3 minutes. Display rate is 
10 frames/sec. The superimposition of frames from this movie is shown in Figure 2F (middle 
and right images). Scale bar, 10 m. Typical sequence is shown; 21 cells from n=2 
independent experiments were examined. 
 
 
Supplementary movie 2 
The microtubule plus ends were randomly distributed over adhesive islands and 
spaces between them in HT1080 cell depleted of KANK1 and KANK2 
 
A representative cell of three independent experiments is shown. Cell with focal adhesion 
labeled with GFP-vinculin (red) and microtubule plus tips labeled with mKO-EB3 (green) was 
imaged using SIM. Single plane close to the substrate is shown. The frames were recorded 
at 1-second intervals over a period of 3 minutes. Display rate is 10 frames/sec. The 
superimposition of frames from this movie is shown in Figure 2G (middle and right images). 
Scale bar, 10 m. Typical sequence is shown; 18 cells from n=2 independent experiments 
were examined. 
 
 
Supplementary movie 3 
Microtubule outgrowth induced transient disassembly of focal adhesions in HT1080 
cell 
 
The imaging started immediately after nocodazole washout. The cell with microtubules 
labeled with GFP-ensconsin (green) and focal adhesions labeled with mApple-paxillin (red) 
was imaged using a spinning disk confocal microscopy. For microtubules, z-projection of all 
focal planes is shown; for focal adhesions, single plane near the substrate is shown. The 
frames were recorded at 30-seconds intervals over a period of 30 minutes. Display rate is 10 
frames/sec. Scale bar, 10 m. Typical sequence is shown; 9 cells from n=4 independent 
experiments were examined. 
 
Supplementary movie 4 
Rapamycin-induced linking of two parts of KANK1 molecule triggered disassembly of 
focal adhesions in HT1080 cell 
 
Addition of 1 g/ml rapamycin promoted the accumulation of FKBP-KN-mEmerald (red) to 
KN-containing focal adhesions (mApple-KN-FRB, green). The enforced dimerization by 
rapamycin resulted in a transient disassembly of focal adhesions marked by mTFP-vinculin 
(inverted black and white images). Single plane close to the substrate is shown. The frames 
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were recorded at 30-second intervals over a period of 20 minutes using SIM. Display rate is 
5 frames/sec. The movie corresponds to the time-lapse series shown in Figure 2I. Scale bar, 
10 m. Typical sequence is shown; 27 cells from n=6 experiments were examined.  
 
 
Supplementary movie 5 
Microtubule disruption triggered massive assembly of myosin-II filaments and 
disassembly of podosomes in THP1 cell 
 
Disruption of podosomes labeled by RFP-lifeact (red, left) in THP1 cell treated with 1 M 
nocodazole was accompanied by a massive burst of myosin-II filament assembly that 
aligned in stacks, as visualized by GFP-MRLC (green, right) using SIM. Single plane close 
to the substrate is shown. The frames were recorded at 15-second intervals over a period of 
30 minutes using SIM. Display rate is 10 frames/sec. The movie corresponds to the time-
lapse series shown in Figure 2A. Scale bar, 5 m. Typical sequence is shown; 45 cells from 
n=5 experiments were examined. 
 
 
Supplementary movie 6 
Microtubule disruption triggered massive assembly of myosin-II filaments and 
augmentation of focal adhesion in HT1080 cell 
 
Myosin-II filament formation accompanies focal adhesion augmentation in HT1080 cell 
treated with 1 M nocodazole. Focal adhesions are labeled with mApple-paxillin (red), 
myosin-II filaments are labeled with GFP-MRLC (green) and imaged using SIM. The imaging 
started immediately after nocodazole addition. Single plane close to the substrate is shown. 
The frames were recorded at 1-minute intervals over a period of 30 minutes. Display rate is 
10 frames/sec. The movie corresponds to the time-lapse series shown in Figure 3B. Scale 
bar, 10 m. Typical sequence is shown; 19 cells from n=2 experiments were examined. 
 
 
Supplementary movie 7 
Microtubule outgrowth induced disassembly of myosin-II filaments in HT1080 cell  
 
Microtubules are labeled with mApple-MAP4 (left) and myosin II filaments are labeled with 
GFP-MRLC (right) and imaged using SIM. The imaging started immediately after 
nocodazole washout. For microtubules, z-projection of all focal planes is shown; for myosin-
II filaments, single plane near the substrate is shown. The frames were recorded at 15 
seconds intervals over a period of 10 minutes. Display rate is 10 frames/sec. The movie 
corresponds to the time-lapse series shown in Supplementary Figure 6A. Scale bar, 10 m. 
Typical sequence is shown; 16 cells from n=3 experiments were examined. 
 
 
Supplementary movie 8 
Transient decrease in traction forces after microtubule outgrowth in HT1080 cell 
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Focal adhesions are labeled with RFP-Zyxin (right) and imaged using spinning disk confocal 
microscopy. Single plane close to the substrate is shown. The imaging started immediately 
after nocodazole washout. Traction stresses (left) computed as described in Materials and 
Method section are presented in spectrum scale (Pa); the scale is shown on the farmost left. 
The frames were recorded at 1-minute intervals over a period of 31 minutes. Display rate is 
10 frames/sec. The movie corresponds to the time-lapse series shown in Supplementary 
Figure 6C. Scale bar, 10 m. Typical sequence is shown; 13 cells from n≥3 experiments 
were examined. 
 
 
Supplementary movie 9 
KANK2 knockdown suppressed disassembly of myosin-II filaments induced by 
microtubule outgrowth in HT1080 cell  
 
The imaging started immediately after nocodazole washout. Microtubules are labeled with 
mApple-MAP4 (left), myosin II filaments are labeled with GFP-MRLC (right) and imaged 
using SIM. For microtubules, z-projection of all focal planes is shown; for myosin-II filaments, 
single plane near the substrate is shown. The frames were recorded at 15-second intervals 
over a period of 5 minutes. Display rate is 10 frames/sec. The movie corresponds to the 
time-lapse series shown in Supplementary Figure 6E. Scale bar, 10 m. Typical sequence is 
shown; 13 cells from n=3 experiments were examined. 
 
 
 
Supplementary movie 10 
Activation of RhoA by CN03 augmented myosin-II filament formation and podosome 
disruption in THP1 cell 
 
Disruption of podosomes labeled by RFP-lifeact (red, left) in THP1 cell treated with 1 g/ml 
CN03 was accompanied by an increased assembly of myosin-II filaments visualized by 
GFP-MRLC (green, right), similar to nocodazole-treated cell. Single plane close to the 
substrate is shown. The frames were recorded at 1-minute intervals over a period of 40 
minutes using SIM. Display rate is 10 frames/sec. The movie corresponds to the time-lapse 
series shown in Supplementary Figure 7C. Scale bar, 5 m. Typical sequence is shown; 12 
cells from n=3 experiments were examined. 
 
 
Supplementary movie 11 
Dynamics of podosomes and myosin-II filaments in control THP1 cell 
 
Podosomes were labeled by RFP-lifeact (red) in THP1 cell treated with 0.2% DMSO. Note 
that myosin-II filaments visualized by GFP-MRLC (green) are localized to the peripheral rim 
of the cell and are absent at sites of podosome assemblies. Single plane close to the 
substrate is shown. The frames were recorded at 10-seconds intervals over a period of 30 
minutes using SIM. Display rate is 10 frames/sec. The movie corresponds to the time-lapse 
series shown in Supplementary Figure 7D. Typical sequence is shown; 10 cells from n=3 
experiments were examined. 
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Supplementary movie 12 
ROCK inhibition by Y-27632 did not affect podosome dynamics in THP1 cell 
 
Inhibition of ROCK by addition of 30 μM Y-27632 induced disassembly of myosin-II filaments 
visualized by GFP-MRLC (green) but did not affect podosome dynamics in THP1 cell. 
Podosomes are labeled by RFP-lifeact (red) and imaged using SIM. Single plane close to 
the substrate is shown. The frames were recorded at 10-seconds intervals over a period of 
30 minutes. Display rate is 10 frames/sec. The movie corresponds to the time-lapse series 
shown in Figure 4A. Scale bar, 5 m. Typical sequence is shown; 25 cells from n=3 
experiments were examined. 
 
 
Supplementary movie 13 
Inhibition of ROCK by Y-27632 disrupted myosin-II filaments and prevented 
nocodazole-induced disassembly of podosomes in THP1 cell  
 
The imaging started at the 30th minute after addition of 100 M Y-27632 and was continued 
for another hour in the presence of both Y-27632 and 1 M nocodazole. Single plane close 
to the substrate is shown. The frames were recorded at 2-minute intervals over a period of 
40 minutes. Podosomes and myosin II filaments are labeled with RFP-lifeact (red) and GFP-
MRLC (green), respectively, and imaged by SIM.  The movie corresponds to the time-lapse 
series shown in Supplementary Figure 7E. Scale bar, 5 m. Typical sequence is shown; 32 
cells from n=3 experiments were examined. 
 
 
Supplementary movie 14 
Disruption of myosin-II filaments by Y-27632 resulted in recovery of podosomes in 
THP1 cell pre-treated with nocodazole. 
 
Disassembly of myosin-II filaments by 30 M Y-27632 results in recovery of podosomes in 
THP1 cell pre-treated with nocodazole for 30 minutes as visualized by SIM. Podosomes and 
myosin II filaments are labeled with RFP-lifeact (red) and GFP-MRLC (green), respectively, 
and imaged by SIM. The imaging started at the 30th minute after addition of nocodazole and 
was continued for another hour in the presence of both Y-27632 and 1 M nocodazole. 
Single plane close to the substrate is shown. The frames were recorded at 2-minute 
intervals over a period of 40 minutes. Display rate is 10 frames/sec. The movie corresponds 
to the time-lapse series shown in Supplementary Figure 7F. Scale bar, 5 m. Typical 
sequence is shown; 30 cells from n=3 experiments were examined. 
 
 
Supplementary movie 15 
Disruption of myosin-II filaments by Y-27632 resulted in recovery of podosomes in 
KANK1-depleted THP1 cell 
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Inhibition of ROCK by treatment with 30 M Y-27632 in KANK1-depleted THP1 cell induced 
the formation of de novo podosomes, approximately 30 minutes after addition of the drug. 
Podosomes and myosin-II filaments are labeled with RFP-lifeact (red) and GFP-MRLC 
(green), respectively, and imaged by SIM. Single plane close to the substrate is shown. The 
frames were recorded at 30-second intervals over a period of 60 minutes using SIM. Display 
rate is 10 frames/sec. The movie corresponds to the time-lapse series shown in Figure 4B. 
Scale bar, 5 m. Typical sequence is shown; 20 cells from n=3 experiments were examined. 
 
 
Supplementary movie 16 
Constitutively active RhoA and ROCK prevented the disruption of focal adhesions 
upon microtubule outgrowth in HT1080 cells 
 
Control cell (left) and cells expressing constitutive active form of RhoA (middle) or ROCK 
(right) are imaged just after nocodazole washout by TIRF microscopy. Focal adhesions are 
labeled with mApple-paxillin. The frames were recorded at 30-second intervals over a period 
of 30 minutes. Display rate is 10 frames/sec. The movie corresponds to the time-lapse 
series shown in Supplementary Figure 7L. Scale bar, 10 m. Typical sequence is shown; 17 
cells (control), 22 cells (CA-RhoA) and 10 cells (CA-ROCK) from n≥3 experiments were 
examined. 
 
 
Supplementary movie 17 
GEF-H1 knockdown suppressed disruption of myosin-II filaments and prevented 
disassembly of focal adhesions upon microtubule outgrowth in HT1080 cell 
 
The imaging started immediately after nocodazole washout. Microtubules are labeled with 
mApple-MAP4 (left), myosin II filaments are labeled with GFP-MRLC (right); focal adhesions 
are labeled with mTFP-vinculin (right), and were imaged using SIM. For microtubules, z-
projection of all focal planes is shown; for myosin-II filaments and focal adhesions, single 
planes near the substrate are shown. The frames were recorded at 15 seconds intervals 
over a period of 10 minutes. Display rate is 10 frames/sec. The movie corresponds to the 
time-lapse series shown in Supplementary Figure 10I. Scale bar, 10 m. Typical sequence 
is shown; 13 cells from n=3 experiments were examined. 
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